EurekaMag Full Text Articles Chapter 30,103

Wrzos, H.; Abt, P.; Rapp, F. 1989: Anti interferon antibody decreases natural killer cell activity in mice genitally infected with herpes simplex virus type 2. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 145

Bergomi, S.; Zanoni, L.; Caruso, A.; Turano, A. 1991: Anti interferon gamma monoclonal antibody interferes with hiv replication in peripheral blood mononuclear cells. AIDS Research and Human Retroviruses 7(2): 143

Mcintyre, K.W.; Chizzonite, R.A.; Stern, A.S.; Plocinski, J.M.; Kaffka, K.L.; Benjamin, W.R.; Kilian, P.L. 1989: Anti interleukin 1 il 1 receptor antibody decreases neutrophil pmn accumulation in the peritoneal cavities of mice injected with proteose peptone pp. FASEB Journal 3(3): A316

Via, C.; Finkelman, F. 1991: Anti interleukin 2 il2 treatment in vivo converts acute murine graft vs host disease gvhd to a lupus like disease. FASEB Journal 5(4): A646

Chensue, S.; Terebuh, P.; Evanoff, H.; Higashi, G.; Kunkel, S. 1991: Anti interleukin 4 but not anti interferon antibodies suppress schistosome egg hypersensitivity type granuloma formation. FASEB Journal 5(4): A627

Reith, A.; Rucklidge, G.J.; Bjerkvig, R. 1991: Anti invasive properties of extracellular matrix proteins using an in vitro model system. European Journal of Cancer 27(Suppl 3): S36

Punt, N.C.; Robbillard, G.T.; Tamminga, K.S.; Van Amsterdam, F.T.M.; Zaagsma, J. 1990: Anti ischemic activity of dl cis diltiazem in relation to energy metabolism in the isolated perfused rat heart a phosphorus 31 nmr study. European Journal of Pharmacology 183(3): 789

Grover, G.J.; Sleph, P.G.; Dzwonczyck, S.; Parham, C.S. 1989: Anti ischemic and anti fibrillatory effects of the potassium channel activators cromakalim and pinacidil in dog and isolated rat hearts. Circulation 80(4 Suppl 2): II499

Thomassen, A.; Nielsen, T.T.; Bagger, J.P.; Pedersen, A.K.; Henningsen, P. 1991: Anti ischemic and metabolic effects of glutamate in angina pectoris. European Heart Journal 12(ABSTR Suppl): 400

Barbour, M.M.; Garber, C.E.; Ahlberg, A.W.; Cloutier, D.J.; Mcclellan, J.R.; Heller, G.V. 1992: Anti ischemic effect of theophylline a concentration dependent phenomenon. Journal of the American College of Cardiology 19(3 Suppl A): 241A

Bril, A.; Ben Baoulai, A.; Rochette, L. 1990: Anti ischemic effects of bepridil and cerm 4205 in the rat. European Journal of Pharmacology 183(3): 786-787

Visser, F.C.; Sloof, G.W. 1991: Anti ischemic effects of l propionylcarnitine in patients with stable angina pectoris. European Heart Journal 12(ABSTR Suppl): 344

Rahman, F.; Yaoka, O.; Nakajima, T. 1992: Anti ischemic effects of y 26763 an active metabolite of potassium channel opener y 27152 in isolated perfused rat hearts. Japanese Journal of Pharmacology 59(Suppl 1): 107P

Scatton, B.; Carter, C.J.; Benavides, J.; Dana, C.; Gotti, B. 1991: Anti ischemic potential of the polyamine modulatory site antagonists ifenprodil and sl 820715. Meldrum, B S , Et Al Fidia Research Foundation Symposium Series, Vol 5 Excitatory Amino Acids; Symposium, Montegrotto Terme, Italy, May 21-26, 1990 Xxxv+780p Raven Press: New York, New York, Usa Illus 443-450

Estrada J.N.; Saglietti H.; Di Marco M.; Casabe H.; Oliveri R. 1989: Anti ischemic properties of amlodipine a new calcium channel blocker in patients with severe coronary artery disease a prospective trial. European Heart Journal 10(ABSTR Suppl): 53

Stadler, B.M.; Gauchat, D.; Vassella, C.; Kazunori, N.; Qui, G.; Gauchat J F. 1989: Anti isotype regulation cytokines and anti ige autoantibodies. Sorg, C (Ed ) Cytokines, Vol 2 Cytokines Regulating The Allergic Response Viii+105p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 37-50

Rubin, L.A.; Shi, M.H.; Tsui, F.W.L. 1990: Anti jo 1 binds antigen in the cytoplasm of human myoblast cells. Clinical Research 38(2): 316A

Henrick, C.A.; Carney, R.L.; Brown, T.L.; Lui, A.S.T.; Woo, S.L.; Staal, G.B.; Cerf, D.C. 1991: Anti juvenile hormone agents. Abstracts of Papers American Chemical Society 202(1-2): AGRO 3

Youngs, D.A.; Nelson, K.A. 1990: Anti kappa anti lambda and anti fab antiglobulin reagents. Human Immunology (ABSTR ED): 60

Wagner, M.; Kim, J.; Mujumdar, R.; Mujumdar, S.; Chao, J.; Ernst, L.; Waggoner, A. 1990: Anti kappa anti lambda surface expression analyzed via multi parameter flow cytometry and multiple leukocyte phenotyping. Cytometry (Suppl 4): 93

Maruiwa, M.; Narula, N.; Moscicki, R.; Bhan, A. 1991: Anti kca 3 a monoclonal antibody reactive with a rat complement receptor distinguishes kupffer cells from other macrophages. FASEB Journal 5(5): A1351

Carteron, N.L.; Wofsy, D. 1991: Anti l3t4 antibody therapy in systemic lupus erythematosus. Kresina, T F (Ed ) Inflammatory Disease And Therapy: Monoclonal Antibodies, Cytokines, And Arthritis: Mediators Of Inflammation And Therapy Xvi+516p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 289-312

Bruijn J.A.; Van Leer E.H.G.; Corver W.E.; Hogendoorn P.C.W.; De Heer E.; Hoedemaeker P.J.; Fleuren G.J. 1989: Anti laminin and anti gp90 autoantibodies in experimental lupus nephritis. Kidney International 35(1): 341

Fiavey, N.P.; Ngwenya, B.Z. 1991: Anti leishmanial activity of ether analogues of lysophospholipids. American Journal of Tropical Medicine and Hygiene 45(3 Suppl): 119-120

Niedecken, H.W.; Reinhold, U.; Bauer, R.; Kreysel, H.W. 1989: Anti leu 19 monoclonal antibody reacts with autonomic nerves of human skin. Tissue Antigens 33(2): 302

Ackerstein, A.; Karussis, U.V.; Kedar, E.; Slavin, S. 1992: Anti leukemia efficacy of high dose recombinant interleukin ril2 therapy in relation to route of administration in a murine model of b cell leukemia lymphoma bcl1. Experimental Hematology (Charlottesville) 20(6): 724

Cahn, J.Y.; Bordigoni, P.; Souillet, G.; Pico, J.L.; Bergerat, J.P.; Plouvier, E.; Reiffers, J.; Lutz, P.; Benz Lemoine, E.; Herve, P. 1990: Anti leukemic activity of the tam protocol prior to bone marrow transplantation bmt for patients with high risk acute lymphoblastic leukemia all. Experimental Hematology 18(6): 665

Preijers F.; De Witte T.; Wessels J.; Haanen C. 1990: Anti leukemic effect in bone marrow grafts after elutriation. Bone Marrow Transplantation 5(Suppl 2): 48

Richardson, B.; Kaplan, A.; Ouddus, J. 1991: Anti lfa 1 treatment prevents deletion of self reactive t cells. Arthritis and Rheumatism 34(9 Suppl): S77

Pachner, A.R.; Itano, A.; Ricalton, N.; Mccallum, R. 1990: Anti ligand antibodies as receptors anti bungarotoxin monoclonal antibodies can mimic acetylcholine receptor in vitro and in vivo. FASEB Journal 4(7): A2026

Harrell, H.S.IIi; Malone, C.; Yancey, W.B.Jr; Williams, R.C.Jr 1991: Anti light chain antibodies in sle a parameter of anti idiotypic response?. Clinical Research 39(4): 853A

Schneidkraut, M.J.; Knight, L.S.; Fang, I.S.; Wisienwski, M.A.; Bubbers, J.E.; Huntenburg, C.C. 1992: Anti lipid a monoclonal antibody decreased endotoxin induced tumor necrosis factor alpha synthesis in vitro and reduced the mortality rate in rats. FASEB Journal 6(5): A2041

Huntenburg, C.C.; Wisniewski, M.A.; Fang, I.S.; Bubbers, J.E. 1992: Anti lipid a monoclonal antibody mediated inhibition of endotoxin induced cytokine production in vitro. Journal of Cellular Biochemistry Suppl (16 Part C): 171

Devamanoharan, P.S.; Vara, S.D. 1990: Anti lipid peroxidative efficacy of flavonoids in ocular tissues. IOVS Investigative Ophthalmology and Visual Science 31(4): 580

Loftus, J.K.; Leak, A.M.; Goulding, N.J.; Podgorski, M.R.; Godolphin, J.L.; Maddison, P.J.; Woo, P. 1989: Anti lipocortin antibodies are present in all subgroups of juvenile chronic arthritis jca and are unrelated to corticosteroid therapy. British Journal of Rheumatology 28(Suppl 2): 35-36

Peters, V.B.; Rubin, L.G.; Bpf Study Group 1989: Anti lipooligosaccharide los antibody ab does not protect against experimental bacteremia with a brazilian purpuric fever bpf isolate of haemophilus influenzae biogroup aegyptius hae. Pediatric Research 25(4 Part 2): 187A

Peters V.B.; Rubin L.G.; Et Al 1990: Anti lipooligosaccharide los antibody blocks protective activity of antiserum in experimental bacteremia due to a brazilian purpuric fever bpf isolate of haemophilus influenzae biogroup aegyptius. Pediatric Research 27(4 Part 2): 179A

Ziegler, E.J. 1992: Anti lps monoclonal antibodies. Journal of Cellular Biochemistry Suppl (16 Part C): 157

Sommerauer, J.F.; Howard, J.; Ghent, C.; Grant, D.; Wall, W. 1991: Anti lymphocyte globulin alg vs okt 3 for induction immunosuppression irx in pediatric liver transplantation lt. Clinical and Investigative Medicine 14(4 Suppl): A139

Goni, M.A.; Ayape, M.L.; Redondo, M.; Ezpeleta, I.; Labaca, M.A.; Olcoz, M.; Solana, J.M.; Oyarzabal, F.J. 1991: Anti m antibody in a m positive patient. Biologia and Clinica Hematologica 13(1): 37-40

Klein, R.; Berg, P.A. 1990: Anti m9 antibodies ab in sera from patients with primary biliary cirrhosis pbc recognize an epitope of glycogen phosphorylase ph. Journal of Hepatology 11(Suppl 2): S35

Ilyas, A.A.; Cook, S.D.; Dalakas, M.C.; Mithen, F.A. 1992: Anti mag igm paraproteins from some patients with polyneuropathy associated with paraproteinemia also react with sulfatide. Neurology 42(4 Suppl 3): 333

Nath, J.; Schneider, I. 1992: Anti malarial effects of the anti tubulin herbicide trifluralin studies in plasmodium falciparum. Clinical Research 40(2): 331A

B.C.; Saunders, J.; Soltani, K.; Lautz, D.; Danielson, J.; Franklin, W.; Gottlieb, L. 1989: Anti melanocyte autoantibodies and vitiligo. Clinical Research 37(2): 715A

Kochevar, J.; Kochevar, D.T.; Amoss, M.; Hightower, D. 1989: Anti melanoma antibodies localize iodine 131 to melanomatous lesions in sinclair swine expressing congenital tumors. Proceedings of the American Association for Cancer Research 30: 347

Kapur, R.P.; Bigler, S.J.; Mcgrath, E.; Skelly, M.; Gown, A.M. 1991: Anti melanoma antibody hmb45 identifies an oncofetal premelanosome associated glycoprotein. Laboratory Investigation 64(1): 105A

Ishihara, M.; Hashimoto, K.; Taniguchi, Y.; Cho, K.H.; Setoyama, M.; Richards, J.; Benedetto, L.G.; Pietruk, T.; Mehregan, A.H. 1989: Anti melanoma monoclonal antibody which has a high sensitivity and specificity ikh 1 in formalin fixed paraffin embedded tissue. Clinical Research 37(2): 718A

Pinerolo, C.; Bernasconi, P.; Fornasieri, A.; Armelloni, S.; Min, L.; Fellin, G.; Gibelli, A.; D'amico G. 1992: Anti mesangial cell antibodies detected with elisa method in iga mesangial nephropathy igagn. Kidney International 41(3): 697-698

Christensson, P.I.; Hartely Asp, B. 1991: Anti metastatic effect of linomide a new immunomodulator. Proceedings of the American Association for Cancer Research 32: 406

Mahafzah, M.; Khan, M.; Tourbaf, K.; Dascari, K.; Ambrus, J. 1990: Anti metastatic effect of meclomen. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 174

Doerr, R.; Goldrosen, M.H.; Cohen, S.A. 1990: Anti metastatic role of the liver from beige mice against the mca 38 colon derived tumor. Proceedings of the American Association for Cancer Research 31: 247

Caterini, J.; Caplan, B.; Zobrist, G.; Chong, P.; Boux, H.; Klein, M. 1992: Anti mhc class ii monoclonal antibodies immunotarget hiv peptides in mice and macaques. Journal of Cellular Biochemistry Suppl (16 Part D): 27

SonaliAlkari; AlkaChaturvedi 2008: Anti microbial activities of various crude extracts of some common weeds. Journal Of Plant Disease Sciences: 2, 243-245

Mehta, A.; Chopra, S.; Mehta, P.; Kharaya, M.D. 1979: Anti microbial activity of some essential oils against certain pathogenic bacteria. Bulletin of the Botanical Society University of Saugar 25-26: 14-16, 1978

Korol, B.; Nathan, P. 1989: Anti microbial sensitivity test and testing stratum us patent 4820292 april 11 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(2): 1088-1089

Lombes, M.; Rafestin Oblin M E.; Baulieu E E.; Erlanger, B.F. 1991: Anti mineralocorticoid receptor antibodies anti idiotypic and anti peptide strategies. Bonvalet, J -P , Et Al (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 215 Aldosterone: Aspects Fondamentaux; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 215 Aldosterone: Fundamental Aspects); International Symposium, Fontevraud, France, June 24-26, Xvii+358p Editions Inserm: Paris, France; John Libbey Eurotext: Paris, France Illus Paper 33-44

Liang, D.; Schwarzenbach, F.; Lauterburg, B.H. 1991: Anti mitochondrial antibodies ama do not impair mitochondrial function in primary biliary cirrhosis. Journal of Hepatology 13(Suppl 2): S43

Perros, P.; Palmer, J.; Yeaman, S.; Kendall Taylor, P. 1991: Anti mitochondrial antibodies in patients with graves disease do they signify primary biliary cirrhosis?. Journal of Endocrinology 131(Suppl)

Geoghegan, W.; Jordon, R. 1992: Anti mitochondrial igg1 subclass antibodies in pemphigus foliaceus. Journal of Investigative Dermatology 98(4): 589

Shoenfeld Y.; Bakimer R.; Moutsopoulos H.; Tzioufas A.G.; Youinou P.; Isenberg D.A.; Scheinberg M.; Kveder T.; Rozman B.; Et Al 1991: Anti mitochondrial pyruvate dehydrogenase autoantibodies in autoimmune rheumatic diseases. Molecular Biology Reports 15(3-4): 212

Hartley Asp, B.; Eklov, S.; Bjork, P.; Larsson, A.; Nilsson, S. 1991: Anti mitotic effect of estramustine in vivo. Proceedings of the American Association for Cancer Research 32: 329

Kasprzyk, P.G.; Difiore, P.P.; Fleming, T.P.; King, C.R. 1990: Anti mitotic effects of anti erb b 2 monoclonal antibodies both in vitro and in vivo. Proceedings of the American Association for Cancer Research 31: 309

Michetti, P.; Fasel, N.; Schaerer, E.; Perregaux, C.; Weltzin, R.; Kraehenbuhl J P. 1989: Anti mmtv secretory iga and their protective role against virally induced mammary carcinoma. Experientia 45(ABSTR): A59

Brand, D.; Watson, W.; Whittington, K.; Stuart, J.; Rosloniec, E.; Kang, A. 1995: Anti mouse alpha-1 -CB11 antibody epitope profiles differ between chick alpha-1 -CB11 immunized collagen arthritis susceptible and resistant mice. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 622

Wahl, R.L.; Barrett, J.; Fisher, S. 1989: Anti mouse antibody effects on biodistribution of intact and fab fragments of monoclonal antibodies animal studies. Journal of Nuclear Medicine 30(5 Suppl): 847

Schliephake, D.; Schimpl, A. 1995: Anti mu-F -2 primed B cells stimulated with LPS fail to express J chain and Blimp-1 specific mRNA but show high levels of I-gamma-1 sterile transcripts. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 264

Josso, N.; Picard, J.Y.; Vigier, B. 1991: Anti muellerian hormone and male phenotype development. Negro-Vilar, A And G Perez-Palacios (Ed ) Serono Symposia Publications From Raven Press, Vol 71 Reproduction, Growth And Development; Meeting, Acapulco, Mexico, 1990 Xv+440p Raven Press: New York, New York, Usa Illus 13-20

Harbison, M.D.; Josso, N.; Magid, M.; Minninberg, D.; New, M.I. 1991: Anti muellerian hormone levels in three intersex infants. Pediatric Research 29(4 Part 2): 78A

Josso, N.; Vigier, B.; Picard J Y. 1990: Anti muellerian hormone overdose. M-S (Medecine Sciences) 6(7): 694-695

Swaenepoel, C.; Adamsbaum, C.; Brauner, R.; Chaussain, J.L.; Josso, N. 1991: Anti muellerian hormone serum levels are decreased in boys with congenital hypopituitarism. Hormone Research 35(Suppl 2): 50

Libri, V.; Das, B.; Constanti, A. 1991: Anti muscarinic effects of some ganglionic nicotinic receptor agonists in guinea pig olfactory cortex slices. British Journal of Pharmacology 104(Proceedings Suppl DEC): ABSTRACT 459P

Brouwer, E.; Huitema, M.G.; Klok, P.A.; Cohen Tervaert, J.W.; Weening, J.J.; Kallenberg, C.G.M. 1992: Anti myeloperoxidase antibodies contribute to damage in mpo hydrogen peroxide h 2o 2 halide mediated glomerular injury. Journal of the American Society of Nephrology 3(3): 577

Brouwer, E.; Huitema, M.G.; Klok, P.A.; Cohen Tervaert, J.W.; Weening, J.J.; Kallenberg, C.G.M. 1992: Anti myeloperoxidase mpo associated proliferative glomerulonephritis and vasculitis an animal model. Journal of the American Society of Nephrology 3(3): 577

York, J.C.; Lavery, J.P.; Lisse, J.R.; Grant, J.A. 1992: Anti ndna antibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus and cerebritis. Journal of Allergy and Clinical Immunology 89(1 Part 2): 288

Rephaeli, A.; Rabizadeh, E.; Aviram, A.; Shaklai, M.; Ruse, M.; Nudelman, A. 1990: Anti neoplastic activity of butyric acid prodrug. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 315

Strobach, S.; Masih, A.; Nakamine, H.; Linder, J. 1990: Anti nerve growth factor receptor marks dendritic reticulum cells drc in paraffin embedded lymph nodes. Laboratory Investigation 62(1): 96A

Rosberger, D.F.; Cunningham Rundles, S.; Polsky, B.; Heinemann, M.H. 1990: Anti neurofilament and anti retinal antibodies in sera from aids patients with cytomegalovirus retinitis. IOVS Investigative Ophthalmology and Visual Science 31(4): 224

Loeffler, D.A.; Brickman, C.M.; Kapatos, G.; Peter, J.B.; Lewitt, P.A. 1991: Anti neuronal antibodies and other markers of immune system activation in parkinsons disease. Society for Neuroscience Abstracts 17(1-2): 1261

Verghese, M.W.; Brown, T.A.; Irsula, O.; Ropchak, T.G.; Frangakis, C. 1989: Anti neutrophil activity of cyclic nucleotide phosphodiesterase inhibitors with varying cardiotonic potencies. Journal of Molecular and Cellular Cardiology 21(Suppl 2): S61

Zauli, D.; Ghetti, S.; Grassi, A.; Descovich, C.; Ballardini, G.; Cassani, F.; Muratori, L.; Bianchi, F.B. 1996: Anti neutrophil antibodies in autoimmune hepatitis. Journal of Hepatology 25(Suppl 1): 182

Baffoni, L.; Zauli, D.; Cassani, F.; Fusconi, M.; Lenzi, M.; Ballardini, G.; Bianchi, F.B. 1990: Anti neutrophil antibodies in primary sclerosing cholangitis psc. Journal of Hepatology 11(Suppl 2): S4

Reumaux, D.; Colombel, J.F.; Cortot, A.; Noel, L.H.; Paris, J.C.; Duthilleul, P. 1991: Anti neutrophil antibodies in sera from patients with inflammatory bowel disease. Gastroenterology 100(5 Part 2): A609

Zauli, D.; Ghetti, S.; Grassi, A.; Descovich, C.; Ballardini, G.; Cassani, F.; Muratori, L.; Bianchi, F.B. 1996: Anti neutrophil antibodies in the two types of autoimmune hepatitis. Hepatology 24(4 Part 2): 602A

L.S.K.; Chessman, P.; Mieli Vergani, G.; Fleming, K.A.; Chapman, R.W.G. 1991: Anti neutrophil antibody a test for pediatric autoimmune primary sclerosing cholangitis?. Hepatology 14(4 Part 2): 194A

Bindi, P.; Noel, L.H.; Mougenot, B.; Mentre, F.; Vanhill, P.; Lesavre, P.; Mignon, F.; Ronco, P. 1991: Anti neutrophil cytoplasm antibodies anca specificities in pauci immune necrotizing crescentic glomerulonephritis ncgn. European Journal of Clinical Investigation 21(2 Part 2): 9

Walmsley, R.S.; Zhao, M.; Hamilton, M.I.; Brownlee, A.; Chapman, P.; Pounder, R.E.; Wakefield, A.J.; Lockwood, C.M. 1996: Anti neutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gastroenterology 110(4 Suppl): A1041

Walmsley, R.S.; Zhao, M.; Hamilton, M.I.; Brownlee, A.; Chapman, P.; Dooley, J.S.; Wakefield, A.J.; Lockwood, C.M. 1996: Anti neutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in primary sclerosing cholangitis. Gastroenterology 110(4 Suppl): A1357

Birdi, N.; Laxer, R.M.; Silverman, E.D. 1991: Anti neutrophil cytoplasmic antibodies anca in kawasaki disease. Arthritis and Rheumatism 34(9 Suppl): S70

Barbas, C.S.V.; Stiel, A.R.; Amato, M.B.P.; Carvalho, C.R.R.; Barbas Filho, J.V. 1992: Anti neutrophil cytoplasmic antibodies anca in pulmonary granulomatous disease. American Review of Respiratory Disease 145(4 Part 2): A232

Daha, M.R.; Hagen, E.C.; Ballieux, B.E.P.B.; Kleyburg Van Der Keur, C.; Van Der Woude, F.J. 1991: Anti neutrophil cytoplasmic antibodies detection by elisa using proteinase 3 isolated from sputum. Journal of the American Society of Nephrology 2(3): 591

Gionchetti, P.; Vecchi, M.; Campieri, M.; Ferretti, M.; Calabresi, C.; Bianchi, M.B.; Belluzzi, A.; De Franchis, R.; Miglioli, M.; Barbara, L. 1995: Anti neutrophil cytoplasmic antibodies from ulcerative colitis patients do not influence respiratory burst of circulating polymorphonuclear leucocytes. Gastroenterology 108(4 Suppl): A823

Proujansky, R.; Hyams, J.S.; Treem, W.R.; Gibney, K.; Fawcett, P.T. 1992: Anti neutrophil cytoplasmic antibodies in childhood ulcerative colitis. Gastroenterology 102(4 Part 2): A681

Alon, U.; Hellerstein, S.; Warady, B.A. 1989: Anti neutrophil cytoplasmic antibodies in drug induced wegener like disease. Pediatric Research 25(4 Part 2): 334A

Maclean, J.; Wong, J.; Niles, J. 1992: Anti neutrophil cytoplasmic antibodies in the churg strauss syndrome. Journal of Allergy and Clinical Immunology 89(1 Part 2): 333

Spronk, P.E.; Horst, G.; Huitema, M.H.; Limburg, P.C.; Tervaert, J.W.llem Cohen; Kallenberg, C.G.M. 1994: Anti neutrophil cytoplasmic antibodies of diverse specificities occur in systemic lupus erythematosus. Arthritis and Rheumatism 37(9 Suppl): S316

Vecchi M.; Bianchi M.; Torgano G.; Meucci G.; Omodei P.; Levati M.; Arrigoni M.T.; De Franchis R. 1992: Anti neutrophil cytoplasmic antibodies p anca are more prevalent in ulcerative colitis patients with clinically aggressive disease. Gastroenterology 102(4 Part 2): A708

Hardarson, S.; Labrecque, D.R.; Mitros, F.A.; Goeken, J.A. 1992: Anti neutrophil cytoplasmic antibody anca associated with cholestatic and inflammatory liver diseases. Gastroenterology 102(4 Part 2): A818

Hardarson, S.; Labrecque, D.R.; Mitros, F.A.; Neil, G.; Goeken, J.A. 1991: Anti neutrophil cytoplasmic antibody anca associated with ulcerative colitis and sclerosing cholangitis. Gastroenterology 100(5 Part 2): A585

Hussaini, S.H.; Shorrock, C.J.; Iqbal, T.; Asquith, P.; Thompson, R.; Langman, M.J.S. 1991: Anti neutrophil cytoplasmic antibody and inflammatory bowel disease. Gastroenterology 100(5 Part 2): A587

Charles, L.A.; Falk, R.J.; Jennette, J.C. 1991: Anti neutrophil cytoplasmic autoantibodies anca against myeloperoxidase mpo have igg subclass restriction. FASEB Journal 5(4): A643

Falk, R.J.; Sartor, R.B.; Jones, D.A.; Jeffries, B.D.; Jennette, J.C. 1990: Anti neutrophil cytoplasmic autoantibodies anca in ulcerative colitis uc. Clinical Research 38(2): 387A

Falk, R.J.; Terrell, R.; Huneycutt Calder, L.; Jeanette, J.C. 1989: Anti neutrophil cytoplasmic autoantibodies anca stimulate neutrophil activation in vitro. Kidney International 35(1): 346

Roberts, D.E.; Peebles, C.L.; Curnutte, J.T.; Tan, E.M. 1991: Anti neutrophil cytoplasmic autoantibodies anca to a cytosol specific non granule associated protein. Arthritis and Rheumatism 34(9 Suppl): S70

Reumaux, D.; Colombel, J.F.; Cortot, A.; Noel, L.H.; Lesavre, P.; Duthilleul, P. 1991: Anti neutrophil cytoplasmic autoantibodies directed against cathepsin g in sera from patients with inflammatory bowel disease. Gut 32(10): A1218

Shanahan, F.; Duerr, R.; Rotter, J.I.; Yang, H.; Sutherland, L.; Mcelree, M.; Landers, C.; Targan, S.R. 1991: Anti neutrophil cytoplasmic autoantibodies in ulcerative colitis a family study with evidence for genetic heterogeneity. Clinical Research 39(1): 95A

Charles, L.A.; Falk, R.F.; Jennette, J.C. 1990: Anti neutrophil cytoplasmic autoantibody anca reactivity with mononuclear phagocytes cultured in vitro. FASEB Journal 4(7): A2255

Jennette, J.C.; Falk, R.J. 1989: Anti neutrophil cytoplasmic autoantibody associated glomerulonephritis anca gn pathologic features. Kidney International 35(1): 370

O'connor C.R.; Kelley, K.; Reginato, A.J.; Schraeder, P.L.; O'connor W.H. 1989: Anti neutrophil factor in systemic lupus erythematosus sle as determined by mononuclear chemiluminescence cl. Arthritis and Rheumatism 32(4 Suppl): S13

Bautista, A.P.; Spolarics, Z.; Jaeschke, H.; Smith, C.W.; Lang, C.H.; Spitzer, J.J. 1991: Anti neutrophil pmn antibody 1f12ab modulates the metabolism and function of hepatic pmn and kupffer cells kc. Journal of Leukocyte Biology (Suppl 2): 53

Ritter, A.M.; Mendell, L.M. 1990: Anti ngf shortens ap duration of a subset of dorsal root ganglion cells maturing in vivo. Society for Neuroscience Abstracts 16(1): 477

Van Der Zee, E.E.M.; Fawcett, J.; Stanisz, J.; Racine, R.; Diamond, J. 1991: Anti ngf treatment blocks the collateral sprouting of cholinergic fibers in the hippocampus. Society for Neuroscience Abstracts 17(1-2): 1312

Miettinen, A.; Petays, T.; Childhood Diabetes Finl Study Group 1991: Anti nuclear antibodies ana associated with iddm show three distinct binding patterns at hep 2 cells. Acta Endocrinologica Suppl 124(3): 24

Christmas T.J.; Le Page S.; Maddison P.J.; Isenberg D.A. 1989: Anti nuclear antibodies in interstitial cystitis ic. British Journal of Rheumatology 28(Suppl 2): 37

Rader, J.I. 1990: Anti nutritive effects of dietary tin. FASEB Journal 4(4): A922

Iontova, I.; Andrushkevich, T.; Pavlova, E.; Totolian, A. 1992: Anti of test in epidemiology of streptococcal infection. Orefici, G (Ed ) Zentralblatt Fuer Bakteriologie Suppl, 22 New Perspectives on Streptococci And Streptococcal Infections; (International Journal Of Medical Microbiology, 22 New Perspectives on Streptococci And Streptococcal Infections); Xi Lancefield International Symposium on Streptococci And Streptococcal Diseases, Siena, Italy, September 10-14, 1990 Xix+569p Gustav Fischer Verlag: Stuttgart, Germany; New York, New York, Usa Illus 33-35

Snowman, A.M.; Mcenery, M.W.; Sharp, A.H.; Snyder, S.H. 1991: Anti omega conotoxin gvia antibodies a valuable tool for the identification of the omega conotoxin receptor of rat brain. Society for Neuroscience Abstracts 17(1-2): 341

Mcclure, J.E.; Shearer, W.T. 1990: Anti oncogene product p53 may participate in a signal transduction pathway in human b lymphocytes. FASEB Journal 4(7): A2111

Donaldson, K.; Macnee, W.; Brown, D.M. 1991: Anti oxidant inhibitable injury caused to epithelial cells by contact with long fibers of amosite asbestos in vitro. American Review of Respiratory Disease 143(4 Part 2): A603

Fischer, M.; Konig, J.S.; Elmdafa, I.; Balcke, P.; Druml, W. 1992: Anti oxidant status in chronic hemodialysis patients impact of selenium supplementation. Journal of the American Society of Nephrology 3(3): 364

Thurnham, D.I. 1990: Anti oxidant vitamins and cancer prevention. Journal of Micronutrient Analysis 7(3-4): 279-300

Shadid, M.; Moison, R.; Hiltermann, L.; Berger, H.M.; Van Bel, F. 1997: Anti oxidative combination therapy and post hypoxic ischemic reperfusion injury of the newborn brain. Pediatric Research 41(4 Part 2): 296A

Tse, S.Y.H.; Mak, I.T.; Dickens, B.F.; Weglicki, W.B. 1990: Anti oxidative properties of beta carboline derivatives. FASEB Journal 4(3): A627

Dodson, J.M.; Scott, G.K.; Shepard, H.M.; Benz, C.C. 1990: Anti p 185e r b b 2 antibody inhibits phosphorylation of phosphotyrosyl proteins in c erb b 2 overexpressing breast cancer cells. Proceedings of the American Association for Cancer Research 31: 77

Mack, U.; Ukena, D.; Sybrecht, G.W. 1997: Anti p53 autoantibodies as tumor marker in patients with lung cancer. European Respiratory Journal Suppl 10(25): 263S

Barquinero, J.; Selva, A.; Ordi, J.; Molins, A.; Tolosa, C.; Vilardell, M. 1990: Anti paf antibodies in patients with systemic lupus erythematosus primary antiphospholipid syndrome progressive systemic sclerosis and syphilis and its correlation with other antiphospholipid antibodies. British Journal of Rheumatology 29(ABSTR Suppl 2): 106

Byers, V.S. 1990: Anti pan t lymphocyte immunotoxin for therapy of autoimmune diseases preclinical and clinical development. Baldwin, R W , V S Byers And R D Mann (Ed ) Monoclonal Antibodies And Immunoconjugates; Meeting on Monoclonal Antibodies And Immunoconjugates in Cancer Treatment, London, England, Uk, April 6-7, 1989 Xii+209p Parthenon Publishing Group, Inc : Park Ridge, New Jersey, Usa; Carnforth, England, Uk Illus 51-64

Beardslee, S.L.; Papadakis, E.; Fontana, D.J.; Commissaris, R.L. 1989: Anti panic drug treatments failure to affect defensive burying behavior. FASEB Journal 3(3): A295

Goncalves, Adriana R.; De Souza, Wanderley; Soares, Maurilio J.; Alves, Elias W. 1998: Anti parasites effects of Bothrops jararaca venom. Toxicon 36(9): 1274-1275

Schneider, J.S.; Mclaughlin, W.W.; Roeltgen, D.P. 1992: Anti parkinson effects of the selective dopamine d 2 agonist n 0923 in hemi parkinsonian monkeys. Neurology 42(4 Suppl 3): 443

Gurish, M.F.; Stevens, R.L.; Ghildyal, N.; Austen, K.F.; Mcneil, H.P.; Nicodemus, C.F. 1992: Anti peptide antibodies against mast cell mc proteases development of highly specific antibodies against mouse mc protease 2 mmcp 2 mouse mc protease 5 mmcp 5 and mouse mc carboxypeptidase a mc cpa. FASEB Journal 6(5): A1723

Mcneil, H.P.; Frenkel, D.J.; Austen, K.F.; Stevens, R.L. 1992: Anti peptide antibodies against mast cell mc serine proteases development of a highly specific antibody against mouse mc protease 5 mmcp 5. Journal of Allergy and Clinical Immunology 89(1 Part 2): 245

Gurish, M.F.; Nicodemus, C.F.; Ghildyal, N.; Austen, K.F.; Stevens, R.L. 1992: Anti peptide antibodies against the exopeptidase mouse mast cell carboxypeptidase a mc cpa. Journal of Allergy and Clinical Immunology 89(1 Part 2): 309

Wangsgard, W.; Dasgupta, M.; Blumenthal, D.K. 1992: Anti peptide antibodies as probes of phosphorylase kinase structure. Biophysical Journal 61(2 Part 2): A339

Davies, A.; Ciardelli, T.L.; Lienhard, G.E.; Baldwin, S.A. 1989: Anti peptide antibodies as probes of the topology and function of the human erythrocyte glucose transporter. Biochemical Society Transactions 17(3): 549

Boersma, W.J.A.; Deen, C.; Gerritse, K.; Zegers, N.D.; Claasen, E.; Haaijman, J.J. 1989: Anti peptide antibodies as subclass specific reagents epitope mapping of human igg 2. Poulik, M D (Ed ) Protides Of The Biological Fluids Proceedings Colloquium, Vol 36 Lipoproteins Igg And Iga Subclasses Cytofluorometry, Meeting, London, England, Uk, April 3-5, Xiii+481p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 161-166

Mayanil, C.S.K.; Hosey, M.M. 1989: Anti peptide antibodies detect muscarinic cholinergic receptor subtypes in brain and heart. Journal of General Physiology 94(6): 23A-24A

David, C.; Fuchs, S. 1990: Anti peptide antibodies localize iodine 125 naps binding to the carboxyl terminal portion of the d 2 dopamine receptor. Society for Neuroscience Abstracts 16(1): 208

Henry, S.; Epstein, J.S.; Liang C M. 1990: Anti peptide antibodies show comigration of matrix protein and a potential p17 precursor of p7 nucleocapsid protein in hiv 1 western blots. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Fa 328

Purcell, D.F.J.; Johnstone, R.W.; Mckenzie, I.F.C. 1991: Anti peptide antibodies specific for three different cd46 mcp isoforms. Complement and Inflammation 8(3-4): 213-214

Strang, P.F.; Mash, D.C.; Flynn, D.D. 1989: Anti peptide antibodies to m1 muscarinic receptors specifically label cortical neurons. Society for Neuroscience Abstracts 15(1): 811

Sioussat, T.M.; Dvorak, H.F.; Senger, D.R. 1991: Anti peptide antibodies to vascular permeability factor. Journal of Cell Biology 115(3 Part 2): 264A

Rahman, M.U.; Ahmed, S.; Schumacher, H.R.; Zeiger, A.R. 1989: Anti peptidoglycan antibodies in psoriatic arthritis and other rheumatic diseases. Arthritis and Rheumatism 32(4 Suppl): S112

Scevola, D.; Zambelli, A.; Gambino, R.; Guanziroli, A.; Franchini, A. 1990: Anti peroxidizing polyunsaturated phosphatidylcholine. Alimentazione Nutrizione Metabolismo 11(1): 7-28

Lian C J.; Pai, C.H. 1990: Anti phagocytic role of plasmid mediated cell surface components of yersinia enterocolitica. Journal of Cellular Biochemistry Suppl (14 Part C): 170

Aoki, K. 1992: Anti phospholipid antibodies and habitual miscarriages. Clinical Gynecology and Obstetrics 46(2): 193-196

Fujino, T.; Iwamoto, I.; Takesako, S.; Shiokawa, H.; Nagata, Y. 1991: Anti phospholipid antibodies apa induced by immunization with lymphocytes in primary recurrent spontaneous aborters rsa effect of apa on trophoblast proliferation. International Journal of Gynecology and Obstetrics (ABSTR Suppl): 51

Anderson, B.D.; Myones, B.L. 1990: Anti phospholipid antibodies contribute to the decreased c3b receptor cr1 number in juvenile rheumatoid arthritis jra. Arthritis and Rheumatism 33(9 Suppl): S119

Yoshikawa, M.; Aoki, K.; Hayashi, Y.; Kajiura, S.; Yagami, Y. 1990: Anti phospholipid antibodies eluted from human placental tissue. American Journal of Reproductive Immunology 22(3-4): 84

Piqueroa, F.; Berrios, X.; Gutierrez, M.; Carrion, F.; Goycolea, J.P.; Reidel, I.; Jacobelli, S. 1990: Anti phospholipid antibodies in active and inactive rheumatic fever patients with and without chorea. Arthritis and Rheumatism 33(9 Suppl): S164

Myones, B.L.; Anderson, B.D.; Rivas Chacon, R.F.; Mercer, W.D. 1990: Anti phospholipid antibodies in juvenile rheumatoid arthritis jra. Arthritis and Rheumatism 33(9 Suppl): S93

Hashiba, H.; Ina, Y.; Takada, K.; Yamamoto, M.; Noda, M.; Sato, T.; Miyachi, A.; Ito, S.; Sato, S.; Morishita, M. 1991: Anti phospholipid antibodies in sarcoidosis. American Review of Respiratory Disease 143(4 Part 2): A217

Mccarty, G.A.; Lister, K.A. 1990: Anti phospholipid antibody apl primary antiphospholipid antibody syndrome aps and rheumatic diseases clinical and immunologic analyses. Arthritis and Rheumatism 33(9 Suppl): S164

Weaver, M.D.; Moore, M.E.; Centeno, L.V.; Stone, K.E. 1991: Anti phospholipid syndrome presenting as stroke in the context of leukocytoclastic vasculitis a case report. Archives of Physical Medicine and Rehabilitation 72(10): 820

Barros, P.J.L.; Gaburo, N.Jr; Barros, V.V.; Zugaib, M.; Cossermelli, W. 1991: Anti phospholipids antibodies and pregnancy report of incidence and complication in patients with lupus. International Journal of Gynecology and Obstetrics (ABSTR Suppl): 384

Jamison, S.R.; Glenney, J.R. 1990: Anti phosphotyrosine antibodies sequence analysis and genetic manipulation to produce an active single chain antibody. Journal of Cell Biology 111(5 Part 2): 216A

Ruff Jamison, S.; Glenney, J.R.Jr 1992: Anti phosphotyrosine antibody fragments expressed in escherichia coli requirement for both heavy and light chain variable region and a unique heavy chain d region for high affinity binding. FASEB Journal 6(4): A1222

Blackstock, R.; Zembala, M.; Asherson, G.L. 1991: Anti picryl tsf inhibits phagocytosis in the same manner as anti cryptococcal tsf the activity is antigen independent. FASEB Journal 5(6): A1706

Elvin Lewis, M.; Lewis, W.H.; Moeller, E. 1989: Anti plaque effects of amazonian jivaro tooth blackening plants. Journal of Dental Research 68(Special Issue): 408

Zepeda, H.; Houk, R.R.; Agarwal, R.P.; Podlasek, S.J. 1991: Anti plasminogen autoantibody in a patient with recurrent deep vein thrombosis. Clinical Chemistry 37(6): 930

Shirahase, H.; Hashizume, Y.; Kanda, M.; Shimaji, H.; Osumi, S.; Kakeya, N. 1989: Anti platelet action of indapamide an anti hypertensive diuretic. Japanese Journal of Pharmacology 49(Suppl): 255P

Iuliucci, J.D.; Treacy, G.; Cornell, S. 1991: Anti platelet activity and safety of chimeric anti platelet monoclonal antibody 7e3 fab combined with streptokinase and anticoagulant drugs. Circulation 84(4 Suppl 2): II247

Takahashi, M.; Kimura, M.; Kunihara, M.; Hayashi, S. 1989: Anti platelet activity of itazigrel in rabbits. Japanese Journal of Pharmacology 49(Suppl): 257P

Yoshimura, Y.; Kamiyama, M.; Arkel, Y.S. 1992: Anti platelet autoantibodies in chronic immune thrombocytopenia differ from those in hiv related immune thrombocytopenia. Clinical Research 40(2): 243A

Chalam, K.V.; Tsao, K.; Hunt, R.C.; Ambati, J.; Tripathi, R.C. 1998: Anti platelet derived growth factor antibody inhibits retinal pigment epithelial cell induced collagen contraction. IOVS Investigative Ophthalmology and Visual Science 39(4): S864

Yamashita, A.; Matsuo, K.; Yokota, K.; Ito, K.; Nurimoto, S. 1990: Anti platelet effect and mode of action of a new anti platelet agent kbt 3022. European Journal of Pharmacology 183(2): 340

Martinuzzo, M.E.; Forastiero, R.R.; Cerrato, G.S.; Adamczuk, Y.; Pombo, G.; Carreras, L.O. 1998: Anti platelet factor 4-heparin antibodies in patients with antiphospholipid antibodies. Lupus 7(Suppl 2): S189

Parravicini, C.L.; Soligo, D.; Berti, E.; Cattoretti, G.; Gaiera, G.; Vago, L. 1989: Anti platelet mabs reactive on endothelial cells immunohistochemistry in normal tissues and vascular neoplasms. Tissue Antigens 33(2): 344

Dotta, F.; Nayak, R.C.; Appel, M.C.; Bonner Weir, S.; Eisenbarth, G.S. 1989: Anti polar antigen a novel antibody of type i diabetic and prediabetic man and nod mouse reacting with rin tumor cells. European Journal of Clinical Investigation 19(2 Part 2): A85

Thibeault, L.; Barakat, S.; Brochu, G.; Lagueux, J.; Muller, S.; Poirier, G.G. 1991: Anti poly adp ribose polymerase parp and anti poly adp ribose autoantibodies in systemic lupus erythematosus characterization and physiological signification. Clinical and Investigative Medicine 14(4 Suppl): A5

Golnick, J.; Park, J.; Blackburn, E.; Lopatin, D.E. 1992: Anti porphyromonas gingivalis titer and avidity in the sera of patients undergoing periodontal therapy. Journal of Dental Research 71(Special Issue): 122

Zanetti, A.R.; Tanzi, E.; Romano, L.; Mari, D.; Colombo, M.; Mannucci, P.M. 1990: Anti pre s2 and anti hbs responses in hemophiliacs vaccinated with a plasma derived vaccine a four year follow up study. Coursaget, P And M J Tong (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 194 Progress in Hepatitis B Immunization; (Inserm (National Institute Of Health And Medical Research) Colloquium), Vol 194 Progress in Hepatitis B Immunization Xlxi+547p Inserm/John Libbey Eurotext: Montrouge, France; London, England, Uk Illus Paper 79-86

Barshaw, D.E.; Spanier, E. 1991: Anti predator behaviors of the slipper lobster scyllarides latus. American Zoologist 31(5): 104A

Whyte, A.; Cheng, J.T.; King, I.S.; Wang, M.W. 1992: Anti progesterone antibodies specifically target the uterus in mice before implantation and up regulate uterine progesterone receptors. Journal of Physiology (Cambridge) 446: 289P

Takagi, M.; Koike, K.; Nakahata, T. 1990: Anti proliferative effect of inf gamma on mouse connective tissue type mast cells. Experimental Hematology 18(6): 719

Leyva, A.; Hijmans, E.M.; Pizao, P.E.; Pinedo, H.M. 1989: Anti proliferative effects of brequinar sodium bs nsc 368390 and other inhibitors of de novo pyrimidine synthesis idnps in vitro. Investigational New Drugs 7(4): 377

Mulshine, J.L.; Avis, I.; Nakanishi, Y.; Cuttitta, F.; Maneckjee, R.; Natale, R.B.; Treston, A.M.; Kasprzyk, P.G.; Jett, M. 1989: Anti proliferative effects of glucagon on small cell lung cancer growth in vitro. Proceedings of the American Association for Cancer Research 30: 61

Pape, K.A.; Floyd Smith, G. 1989: Anti proliferative effects of human interferon beta on human small cell lung carcinoma cell lines. Journal of Cellular Biochemistry Suppl (13 Part B): 38

Becton, D.L.; Roberts, B.; Bryles, P. 1989: Anti proliferative effects on iron chelators in human myeloid leukemia cell lines. Proceedings of the American Association for Cancer Research 30: 576

Dennison, C. 1989: Anti protease peptide antibodies a possible mode of tumor immunotherapy. South African Journal of Science 85(6): 363-364

Sorice, M.; Griggi, T.; Fondacaro, L.M.; Cignarella, L.; Circella, A.; D'agostino F.; Misasi, R. 1992: Anti protein s antibodies in aids. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b217

Berden, J.H.M.; Schrijver, G.; Assmann, K.J.M.; Koene, R.A.P. 1992: Anti proteinuric effect of cyclosporin csa in anti gbm nephritis in the mouse. Journal of Autoimmunity 5(Suppl A): XXXIX

Gray, J.W.; Deighton, C.M.; Cavanagh, G.; Bint, A.J.; Walker, D.J. 1990: Anti proteus antibodies abs in rheumatoid arthritis ra same sexed sibships. British Journal of Rheumatology 29(ABSTR Suppl 2): 102

Atsumi, T.; Ieko, M.; Takeuchi, R.; Horita, T.; Yasuda, S.; Kasahara, H.; Miyoshi, Y.; Ichikawa, K.; Tsutsumi, A.; Koike, T. 1998: Anti prothrombin-phosphatidylserine antibodies and their association with lupus anticoagulant in Japanese patients with autoimmune diseases. Lupus 7(Suppl 2): S222

Kronborg, G.; Fomsgaard, A.; Galanos, C.; Freudenberg, M.A.; Hoiby, N. 1992: Anti pseudomonas aeruginosa lipid a antibodies in chronically infected cystic fibrosis patients. Abstracts of the General Meeting of the American Society for Microbiology 92: 79

Camerlingo, M.; Nemni, R.; Fazio, R.; Casto, L.; Quattrini, A. 1992: Anti purkinje cell antibodies associated subacute sensory neuropathy without malignancy. Neurology 42(4 Suppl 3): 390

Levitus, G.; Hontebeyride Joskowicz, M.; Levin, M. 1990: Anti r13 antibodies in chagas heart disease. Memorias do Instituto Oswaldo Cruz 85(Suppl 1): 68

Steiner, G.; Hassfeld, W.; Sinski, A.; Skriner, K.; Smolen, J. 1991: Anti ra33 a new diagnostic marker for rheumatoid arthritis purification of the antigen and first functional studies. Journal of Cellular Biochemistry Suppl 15(Part E): 167

Hassfeld, W.; Steiner, G.; Graninger, W.; Thalmann, E.; Scherak, O.; Smolen, J.S. 1990: Anti ra33 an autoantibody characteristic for rheumatoid arthritis diagnostic relevance in early disease and partial purification of the antigen. Arthritis and Rheumatism 33(9 Suppl): S96

Engelhardt, P.; Akhmedov, A.T.; Lanzov, V.A. 1990: Anti reca recognize chromosome cores and nodules in meiotic nuclei. Journal of Cell Biology 111(5 Part 2): 376A

Pirenne, J.; Degiovanni, G.; Delhougne, M.; Dunn, D.L. 1990: Anti recipient cytolytic t lymphocytes in rats with graft vs host disease after small bowel transplantation. Human Immunology (ABSTR ED): 104

Elmatteet, M.S.; Omran, M.A.; Elabd, S.; Elmahroky, A.S.; Elshaer, A.; Candil, G.A. 1992: Anti reflux procedures applied in the ileal y shaped neobladder tanta pouch and its modification j shaped pouch. Journal of Urology 147(4 Suppl): 391A

Nicholson, M.L.; Donnelly, P.K.; Veitch, P.S.; Bell, P.R.F. 1990: Anti rejection therapy in renal transplantation okt 3 or methylprednisolone?. Nephrology Dialysis Transplantation 5(8): 756

Urata, N.; Mori, Y.; Mizuo, M.; Nakagawa, M.; Marubuchi, S.; Noto, M.; Arai, H. 1995: Anti relapse effect of T-593 on newly developed acute ulcer relapse model in rats. Japanese Journal of Pharmacology 67(Suppl 1): 195P

Carelli, C.; Corvol, P.; Fehrentz J A.; Liu, C.F.; Castro, B.; Guettier, C. 1990: Anti renin immunization an experimental model of a synthetic antihypertensive vaccine. Brown, F , Et Al (Ed ) Vaccines (Cold Spring Harbor), 90 Modern Approaches to New Vaccines Including Prevention Of Aids; Seventh Meeting, September 1989 Xxv+502p Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, Usa Illus Paper 1-6

Greenson, J.K.; Giardiello, F.M.; Lazenby, A.J.; Bayless, T.M.; Yardley, J.H. 1989: Anti reticulin antibodies aras in collagenous colitis cc and lymphocytic microscopic colitis lc vs celiac disease cd. Laboratory Investigation 60(1): 34A

D.K.zak Y.; Thillaye, B.; Jobin, D.; Mirshahi, M.; Faure J P. 1991: Anti retinal antibodies in the development and recurrences of experimental autoimmune uveoretinitis effect of cyclosporin a. Documenta Ophthalmologica 77(2): 100-101

Mochizuki M.; Ni M.; Chan C C. 1989: Anti retinal auto antibodies in endogenous uveitis. IOVS Investigative Ophthalmology and Visual Science 30(3): 278

Jacobsen, K.L.; Rockwood, G.A. 1990: Anti retroviral activity of bovine leukocyte interferon against bovine leukemia leukemia. Journal of Interferon Research 10(Suppl 1): S111

Tam, S.; Weigele, M.; Broger, S.; Mitsuya, H. 1989: Anti retroviral compounds us patent 4837311 june 6 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(1): 516

Cozens, R.M.; Hochkeppel, H.K.; Lazdins, J.K. 1990: Anti retroviral effect of a novel hybrid recombinant ifn alpha bdbb cgp 35 269. Journal of Interferon Research 10(Suppl 1): S110

Broder, S. 1990: Anti retroviral therapy in aids past present and future. AIDS Research and Human Retroviruses 6(1): 45-46

Middleton, E.Jr; Spedding, G.; Ratty, A.; Connell, E.; Sim, I. 1989: Anti reverse transcriptase activity of plant flavonoids. Journal of Allergy and Clinical Immunology 83(1): 190

Littler, T.R. 1990: Anti rheumatic drugs. Orme, M (Ed ) International Encyclopedia Of Pharmacology And Therapeutics, Section 133 Anti-Rheumatic Drugs Xiii+241p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 189-216

Jubb, R.W. 1992: Anti rheumatic drugs and articular cartilage. Reports on Rheumatic Diseases (Series 2) Topical Reviews (20)

Mackenzie, A.R.; Bollinger, P.; Beveridge, T. 1991: Anti rheumatic potential of ix 207 887 a novel non aspirin like agent. Arthritis and Rheumatism 34(9 Suppl): S119

Deretic, D.; Puleo Scheppke, B.; Trippe, C. 1996: Anti rhodopsin C-terminal MAB inhibits formation of rhodopsin-bearing post-Golgi vesicles in a retinal cell-free system. IOVS Investigative Ophthalmology and Visual Science 37(3): S931

Teh, L.S.; Amos, N.; Bedwell, A.E.; Isenberg, D.A.; Williams, B.D. 1990: Anti ribosomal p protein antibodies and neuropsychiatric systemic lupus erythematosus sle. British Journal of Rheumatology 29(ABSTR Suppl 2): 134

Bonfa, E.; Parnassa, A.P.; Rhoads, D.D.; Roufa, D.J.; Wool, I.G.; Elkon, K.B. 1989: Anti ribosome s10 antibodies in patients with lupus and mlr 1pr mice. Arthritis and Rheumatism 32(4 Suppl): S20

Trombitas, K.; Pollack, G.H. 1990: Anti rigor cross bridge angle in normal sarcomeres?. Biophysical Journal 57(2 Part 2): 545A

M.J.; King, N.; Penny, R.; Breit, S.N. 1990: Anti rnp antibody interaction with surface antigen like structure of viable lymphocytes. Journal of Cell Biology 111(5 Part 2): 245A

Goetz, J.; Sibilia, J.; Jahn, I.; Wiesel M L.; Grunebaum, L.; Falkenrodt, A.; Jehl, C.; Uringlambert, B.; Hauptmann, G. 1990: Anti ro positive patients clinical and biological study. Clinical Rheumatology 9(1 Suppl 1): 121-122

Meilof, J.F.; Bantjes, I.; Van Dam, A.P.; Smeenk, R.J. 1990: Anti ro ss a autoantibodies recognize several polypeptides. Clinical Rheumatology 9(1 Suppl 1): 18-19

Hardgrave, K.L.; Harley, J.B.; Hansen, B.U.; Manthorpe, R.; Jacobson, L. 1990: Anti ro ssa antibodies are associated with subclinical sicca complex in random normals. Arthritis and Rheumatism 33(9 Suppl): S82

Hardgrave, K.L.; Harley, J.B.; Hansen, B.U.; Manthorpe, R.; Jacobsson, L. 1990: Anti ro ssa antibodies are related to sicca symptoms in a random sample of the general population. FASEB Journal 4(7): A2103

Moutsopoulos, H.M.; Zerva, L.V. 1990: Anti ro ssa la ssb antibodies and sjogrens syndrome. Clinical Rheumatology 9(1 Suppl 1): 123-130

Horowitz, A.; Trybus, K.M. 1991: Anti rod monoclonal antibodies modulate actin movement by smooth muscle myosin. Journal of Cell Biology 115(3 Part 2): 184A

Fill, M.; Mejia Alvarez, R.; Volpe, P.; Zorzato, F.; Stefani, E. 1990: Anti ryanodine receptor antibodies as probes for ligand gating of single sr calcium release channels. Biophysical Journal 57(2 Part 2): 170A

Atkinson, J.C.; Royce, L.S.; Bermudez, D.K.; Wellner, R.; Pillemer, S.R.; Fox, P.C. 1990: Anti salivary duct cell autoantibodies in primary sjogrens syndrome. Journal of Dental Research 69(Special Issue): 150

Rivera, V.R.; Hewetson, J.F.; Creasia, D.A. 1990: Anti saxitoxin antibody protects against an intravenous or aerosol saxitoxin challenge. FASEB Journal 4(3): A339

Johanet, C.; Chretien, P.; Agostini, M.M.; Abuaf, N. 1990: Anti scl 70 and anticentromere antibodies are markers of two clinical variants of systemic sclerosis. Clinical Rheumatology 9(1 Suppl 1): 94

Verlangieri, A.; Bannon, A.; Fay, M. 1991: Anti scorbutic activity of l ascorbic acid and ester c in the non ascorbate synthesizing ods rat. FASEB Journal 5(4): A588

Goto, Y.; Sakamoto, T.; Higaki, N. 1989: Anti secretory activity of a novel anti ulcer drug dq 2511 is specific to neural mechanisms in the rat. Gastroenterology 96(5 Part 2): A179

Hara, N.; Natsume, Y.; Hara, Y.; Goto, Y. 1989: Anti secretory and anti ulcer effects of gaba related compound 3 amino 3 phenylpropionic acid in the rat. Japanese Journal of Pharmacology 49(Suppl): 190P

Fitzpatrick, L.R.; Pendley, C.E.; Chase, B.J.; Rossi, D.; Jakubowska, A.; Davis, M.; Martin, G.E. 1992: Anti secretory and gastrointestinal protective profile of the gastrin receptor antagonists l 365260 in rats. Gastroenterology 102(4 Part 2): A731

Sigfridsson, K.; Lange, S.; Lonnroth, I. 1995: Anti secretory protein and feed induced lectins in sow and suckling piglet. van Arendonk, J A M Book of Abstracts of the Annual Meeting of the European Association for Animal Production; Book of Abstracts of the 46th Annual Meeting of the European Association for Animal Production: 165

Ropke, C.; Claesson, M.H. 1990: Anti self suppressor veto activity by thymic epithelial cells. Scandinavian Journal of Immunology 32(4): 414

Shuh, M.; Jackson, J.; Sharma, S. 1991: Anti sense dna oligonucleotide approach to inhibit growth of malignant human b cells. Journal of Cellular Biochemistry Suppl (15 Part D): 33

Laurence, J.; Sikder, S.K.; Miller, P.S.; Ts'o P.O.P. 1989: Anti sense oligomers and induction of chronic human immunodeficiency virus 1. Clinical Research 37(2): 414A

Lallier, T.E.; Bronner Fraser, M. 1991: Anti sense oligonucleotides against integrin alpha and beta subunits inhibit the attachment of avian neural crest cells. Journal of Cell Biology 115(3 Part 2): 133A

Lledo, P.M.; Zorec, R.; Vernier, P.; Mason, W.T. 1992: Anti sense oligonucleotides injected with patch clamp techniques reveal involvement of a small gtp binding protein in the control of exocytosis in rat anterior pituitary cells. Journal of Physiology (Cambridge) 452: 298P

Kim, J.H.; Greene, W.C. 1991: Anti sense rev and rex rna response elements selectively inhibit hiv 1 rev and htlv i rex induced gene expression. Clinical Research 39(2): 282A

Field, E.H.; Rouse, T. 1990: Anti sense rna can modulate surface dr7 expression in transfected l54 cells. Journal of Cellular Biochemistry Suppl (14 Part A): 359

Hambor, J.; Schultz, L.; Gould, D.; Tykocinski, M.; Kaplan, D. 1989: Anti sense rna mediated inhibition of cd2 expression in jurkat cells. Journal of Cellular Biochemistry Suppl (13 Part A): 197

Nichols, A.; Rungger, D. 1990: Anti sense rna produced from a pol iii expression vector inhibits gene expression in xenopus embryos. Experientia 46(ABSTR): A32

Kubatiev, A.; Grachev, S.; Smirnov, L.; Bobkov, Y.; Nefedova, T.; Yadigarova, Z.; Turgiev, A.; Yakovlev, M.; Dumayev, K. 1989: Anti shock activity of lipid free radical oxidation inhibitors. Journal of Molecular and Cellular Cardiology 21(Suppl 2): S7

Giardina, E.; Scarantino, G.; Novara, F.; Verga, S.; Triolo, G. 1990: Anti single stranded dna antibodies in type 2 non insulin dependent diabetes association with vascular complications. Diabetologia 33(Suppl): A170

Laguens, R.P.; Vigliano, C.; Argel, M.; Chambo, J.; Meckert, P.C.; Perrone, S.; Favaloro, R. 1997: Anti skeletal muscle glycolipid antibodies as pretransplantation risk factor for acute humoral and cellular rejection in heart transplantation. Journal of Heart and Lung Transplantation 16(1): 78

Lowe, D.; Barton, E.; Blumenthal, D.; Atkinson, M.; Schwane, J. 1991: Anti skeletal muscle troponin 1 peptide antibodies a potential indicator of fiber type specific skeletal muscle damage. Medicine and Science in Sports and Exercise 23(4 Suppl): S145

Olsen, M.L.; Arnett, F.C.; Reveille, J.D. 1990: Anti sm and anti rnp antibodies are associated with distinct and different hla dq alpha and beta chain genes. Arthritis and Rheumatism 33(9 Suppl): S100

Stocks, M.R.; Haynes, G.; Williams, D.G.; Maini, R.N. 1989: Anti sm autoantibodies in the mrl mp lpr lpr mouse polyclonal activation or antigen drive?. European Journal of Clinical Investigation 19(2 Part 2): A83

Retter, M.W.; Davignon, J.L.; Eisenberg, R.A.; Cohen, P.L.; Bloom, D.D.; Pisetsky, D.; Shlomchik, M.; Weigert, M.; Clarke, S.H. 1990: Anti sm hybridomas from mrl lpr mice show diverse variable gene usage and clonality. Arthritis and Rheumatism 33(9 Suppl): S51

Buffalo, M.D.; Miller, J.S. 1983: Anti smoking and the environmental movement. Journal of Environmental Systems 12(4): 321-328, 1982

Fey, M.S. 1989: Anti smoking oral composition us patent 4832994 may 23 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(4): 2571

Perales, J.; Domont, G.B.; Neves Ferreira, A.G.C.; Rocha, S.L.G.; Villela, C.G.; Moussatche, H. 1992: Anti snake venom proteins from didelphidae. Toxicon 30(5-6): 543

Woods, T.H. 1989: Anti snoring device us patent 4817636 april 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(1): 159-160

Prada, A.; Strife, C.F. 1990: Anti solid phase c1q igg subclass distribution in membranoproliferative glomerulonephritis mpgn and sle. FASEB Journal 4(7): A2105

Satoh, H.; Yaginuma, A.; Wada, Y.; Ikegami, K. 1991: Anti spasmodic action of y 26763 an active metabolite of a new potassium channel opener y 27152 in isolated coronary arteries. Japanese Journal of Pharmacology 55(Suppl 1): 333P

Davis, W.M. 1989: Anti spasmodic agents having a heterocyclic ring us patent 4857535 august 15 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(3): 1851

Ben Chetrit, E.; Fischel, R.; Rubinow, A. 1991: Anti ssr ro and anti ssb la antibodies in serum and saliva in sjogrens syndrome. Arthritis and Rheumatism 34(9 Suppl): S102

Machan, Z.; Wilson, R.; Pitt, T.; Cole, P.J.; Taylor, G.W. 1990: Anti staphylococcal activity of pseudomonas aeruginosa. American Review of Respiratory Disease 141(4 Part 2): A335

Lange, C.F. 1992: Anti streptococcal cell membrane monoclonal antibodies anti scm mab were biosynthetically labeled with carbon 14 and employed in vivo to identify antigenic tissue binding sites. FASEB Journal 6(5): A1794

Pischl, P.H.; Lange, C.F. 1991: Anti streptococcal cell membrane monoclonal antibody anti scm mab binds z line component alpha actinin in cardiac and skeletal muscle. FASEB Journal 5(5): A1359

Gulizia, J.M.; Cunningham, M.W.; Mcmanus, B.M. 1992: Anti streptococcal monoclonal antibodies recognize multiple epitopes in human heart valves cardiac myosin vimentin and elastin as potential valvular autoantigens. Orefici, G (Ed ) Zentralblatt Fuer Bakteriologie Suppl, 22 New Perspectives on Streptococci And Streptococcal Infections; (International Journal Of Medical Microbiology, 22 New Perspectives on Streptococci And Streptococcal Infections); Xi Lancefield International Symposium on Streptococci And Streptococcal Diseases, Siena, Italy, September 10-14, 1990 Xix+569p Gustav Fischer Verlag: Stuttgart, Germany; New York, New York, Usa Illus 267-269

Tucker, L.B.; Goldenstein Schaiberg, C.; Miller, L.C.; Schaller, J.G. 1992: Anti streptococcal serology in juvenile rheumatoid arthritis jra. Pediatric Research 31(4 Part 2): 155A

Lynch, M.; Pentecost, B.L.; Littler, W.A.; Stockley, R.A. 1991: Anti streptokinase antibodies and their implications. Circulation 84(4 Suppl 2): II289

Fears, R.; Standring, R. 1992: Anti streptokinase antibodies evidence for lack of influence on thrombolytic response to anistreplase and streptokinase in patients with acute myocardial infarction. European Heart Journal 13(ABSTR Suppl): 308

Quattrini, A.; Corbo, M.; Dodd, J.; Dhaliwal, S.K.; Sadiq, S.A.; Uncini, A.; Lugaresi, A.; Hays, A.P.; Latov, N. 1991: Anti sulfatide antibodies in neuropathy. Journal of Neuroimmunology (Suppl 1): 53

Palu' G.; Grigolon, M.; Maschera, B.; Capobianco, M.L.; Garbesi, A.; Colonna, F.P.; Arcamone, F. 1992: Anti sv40 and anti hiv 1 tat activity of natural and modified oligonucleotides. Antiviral Research 17(Suppl 1): 84

Sundkvist, G.; Lind, P.; Bergstrom, B.; Lilja, B.; Rabinowe, S.L. 1990: Anti sympathetic and anti parasympathetic nerve antibodies in autonomic neuropathy. Diabetologia 33(Suppl): A33

Lennon, V.A.; Brimijoin, W.S.; Lambert, E.H. 1991: Anti synaptic autoimmunity an emerging clinical entity. Journal of Neuroimmunology (Suppl 1): 195

Humphrey P.A.; Fuller G.N.; Archer G.; Zalutsky M.; Kwatra M.; Cook S.; Friedman H.; Vogelstein B.; Wong A.; Et Al 1990: Anti synthetic peptide antibody reacting at the fusion junction of glioma deletion mutant egf receptor egfr. Proceedings of the American Association for Cancer Research 31: 257

Friend S.L.; Oi V.T. 1989: Anti t cell antibodies as adjuvants for immunization. FASEB Journal 3(4): A1135

Lee, V.K.; Cheever, M.A. 1990: Anti t cell receptor antibodies bound to syngeneic red blood cells can induce specific proliferation of anti tumor effector t cells. FASEB Journal 4(7): A2021

Hashim, G.A.; Offner, H.; Vandenbark, A.A. 1991: Anti t cell receptor autoimmunity is responsible for recovery from eae. Journal of Neurochemistry 57(Suppl): S59

Ardman, B.; Bristol, J.; Levy, E.; Kowalski, M.; Ryan, M.; Sodroski, J. 1989: Anti t lymphocyte antibodies detection on cells from hiv 1 infected individuals. Journal of Cellular Biochemistry Suppl (13 Part B): 247

Russell, M.E.; Liau, C.S.; Matsueda, G.R.; Quertermous, T.; Haber, E.; Collen, D.; Homcy, C.J. 1989: Anti t pa antibodies identify epitopes required for the association of t pa with plasminogen activator inhibitor 1 pai 1. Circulation 80(4 Suppl 2): II643

Hege, K.; Daleke, D.; Waldmann, T.A.; Matthay, K.K. 1989: Anti tac and anti transferrin targeted liposomes are effective for specific drug delivery to adult t cell leukemia. Proceedings of the American Association for Cancer Research 30: 391

Rankin, A.C.; Zaim, S.; Powell, A.; Zaim, B.; Brooks, R.; Mcgovern, B.A.; Garan, H.; Ruskin, J.N. 1991: Anti tachycardia pacemaker implantable cardioverter defibrillator in patients with drug refractory ventricular tachycardia. European Heart Journal 12(ABSTR Suppl): 364

Torpey, D.J.IIi; Montelaro, R.C.; Rinaldo, C.R.Jr 1992: Anti tat specific cytotoxic t lymphocytes from human immunodeficiency virus antibody positive individuals. FASEB Journal 6(5): A1727

Wichert, B.; Derendorf, H.; Gonzalez Rothi, R.J.; Schreier, H. 1990: Anti tb drug liposome aerosols formulation characterization stability and uptake by pulmonary alveolar macrophages am in vitro. Acta Pharmaceutica Technologica 36(1): 14S

NeeluSingh; SushilKumar 2008: Anti termite activity of Jatropha curcas Linn biochemicals. Journal Of Applied Sciences And Environmental Management: 3, 67-69

Matsuda M.; Kamei M.; Sugimoto N.; Ma Y.; Hashizume S. 1992: Anti tetanus human monoclonal antibodies with high protective activity. Toxicon 30(5-6): 533

Iruela Arispe, L.; Bornstein, P.; Sage, H. 1991: Anti thrombospondin antibodies enhance tube formation by endothelial cells in vitro. Journal of Cellular Biochemistry Suppl (15 Part F): 246

Duffy, K.N.W.; Duffy, C.M.; Paquin, J.D.; Strawczynski, H. 1991: Anti thrombotic doses of acetyl salicylic acid in the acute phase of kawasaki disease. Arthritis and Rheumatism 34(9 Suppl): S121

Yokota, K.; Yamamoto, N.; Yamashita, A.; Ito, K.; Nurimoto, S. 1990: Anti thrombotic effect of kbt 3022 on experimental thrombosis models. European Journal of Pharmacology 183(5): 1841

Rodrigues, A.; Fonseca, I.; Pereira, I.; Campos, A.; Santos, J.; Beirao, I.; Cabrita, A.; Guimaraes, S. 1996: Anti thrombotic effects of fish oil in patients on CAPD. Nephrology Dialysis Transplantation 11(6): A251

Fabian, R.H.; Rea, H.C. 1990: Anti thy 1 igg undergoes transcytosis following retrograde axonal transport. Society for Neuroscience Abstracts 16(1): 50

Savino, W.; Silva, J.S.; Barbosa, S.D.S.; Dardenne, M.; Santos, R.R.D. 1990: Anti thymic cell autoantibodies in human and murine chronic chagas disease. EOS-Rivista di Immunologia ed Immunofarmacologia 10(4): 204-205

Karatapanis, S.; Lanzani, G.; Millar, A.; Dhillon, A.; Hamon, M.; Rolles, K.; Burroughs, A. 1992: Anti thymocyte globulin as induction immunotherapy in liver transplantation. Journal of Hepatology 16(Suppl 1): S97

Us Krasovec M.; Stanta G.; Kirbis Srebotnik I.; Pogacnik A.; Di Bonito L.; Bonifacio Gori D. 1991: Anti thyroglobulin antibodies in cytopathology. Pathology Research and Practice 187(6): 779

Becks, G.P.; Buckingham, K.D. 1989: Anti thyroid effects of organic iodine agents. Clinical and Investigative Medicine 12(Suppl 4): B27

Hoier Madsen M.; Feldt Rasmussen U.; Bech K.; Bliddal H.; Rasmussen N.G.; Hegedus L.; Hornnes P.J.; Danneskiold Samsoe B.; Rasmusson B.; Et Al 1990: Anti thyroid peroxidase antibodies in autoimmune diseases. Scandinavian Journal of Immunology 32(4): 398

Massart, C.; Guilhem, I.; Gibassier, J.; Nicol, M.; Allannic, H. 1990: Anti thyroid peroxidase antibody and graves disease significance of monitoring after treatment with antithyroid agents. Carayon, P And J Ruf Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale) Vol 207 Thyroperoxydase Et Auto-Immunite Thyroidienne; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 207 Thyroperoxidase And Thyroid Autoimmunity; International Symposium, Marseilles, France, June 28-30, Xvii+361p Les Editions Inserm: Paris, France; John Libbey Eurotext: London, England, Uk Illus Paper 335-336

Baldet, L.; Faure, J.; Jafiol, C. 1990: Anti thyroid peroxidase autoantibodies anti tpo in thyroid disease. Carayon, P And J Ruf (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale) Vol 207 Thyroperoxydase Et Auto-Immunite Thyroidienne; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 207 Thyroperoxidase And Thyroid Autoimmunity; International Symposium, Marseilles, France, June 28-30, Xvii+361p Les Editions Inserm: Paris, France; John Libbey Eurotext: London, England, Uk Illus Paper 331-332

Bali J P.; Magous, R.; Ammor, S.; Mingard, P.; Combepine, G. 1990: Anti tissue antisera serine 292 serine 278 cause contraction of isolated smooth muscle cells from gastric antrum. European Journal of Pharmacology 183(6): 2186

Scheringa M.; De Bruin R.W.F.; Heineman E.; Jeekel J.; Marquet R.L. 1991: Anti tnf alpha serum prolongs small bowel allograft survival. Cytokine 3(5): 503

Dhainaut J.F.; Fisher C.J.; Opal S.M.; Zimmerman J.; Nightingale P.; Harris S.J.; Schein R.L.; Panacek E.A.; Vincent J.L.; Et Al 1992: Anti tnf igg monoclonal antibody cb0006 in sepsis syndrome pharmacokinetics safety and role of pretreatment il 6 as a predictor of time of survival. American Review of Respiratory Disease 145(4 Part 2): A318

Thoma, B.; Maxeiner, B.; Grell, M.; Pfizenmaier, K.; Scheurich, P. 1990: Anti tnf receptor antibody h 398 completely antagonizes tnf responses but only partially inhibits tnf binding. Lymphokine Research 9(4): 574

Kwiatkowski D.; Molyneux M.; Pointaire P.; Curtis N.; Klein N.; Smit M.; Allan R.; Stephens S.; Brewster D.; Et Al 1991: Anti tnf therapy in human cerebral malaria. Cytokine 3(5): 497

Kasturi, K.; Muryoi, T.; Kafina, M.; Cram, D.; Harrison, L.; Sasaki, T.; Bona, C. 1992: Anti topoisomerase i topoi monoclonal autoantibodies maabs from scleroderma and patients and tight skin tsk mouse interact with similar epitopes. FASEB Journal 6(4): A1025

Chieffi, P.P.; Peres, B.A.; Melo, E.O.D.; Kanamura, H.; Brandao, M.M. 1991: Anti toxocara antibodies production in experimentally infected mice by toxocara canis larvae. Revista do Instituto de Medicina Tropical de Sao Paulo 33(Suppl 8): S42

Feldt Rasmussen M.; Hoier Madsen M.; Bech K.; Hegedus L.; Perrild H.; Bliddal H.; Danneskiold Samso B.; Rasmusson B.; Kriegbaum N.J.; Et Al 1990: Anti tpo antibodies in non thyroid autoimmune disease. Carayon, P And J Ruf (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale) Vol 207 Thyroperoxydase Et Auto-Immunite Thyroidienne; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 207 Thyroperoxidase And Thyroid Autoimmunity; International Symposium, Marseilles, France, June 28-30, Xvii+361p Les Editions Inserm: Paris, France; John Libbey Eurotext: London, England, Uk Illus Paper 297-302

Jaffe, G.J.; Fulcher, S.; Earnest, K.; Lui, G.M.; Houston, L.L. 1990: Anti transferrin receptor immunotoxin inhibits human rpe cell proliferation. IOVS Investigative Ophthalmology and Visual Science 31(4): 69

Recht, L.; Griffin, T.W.; Raso, V.; Salimi, A. 1991: Anti transferrin receptor monoclonal antibody ricin a chain immunotoxins effectively treat solid glioma xenografts. Neurology 41(3 Suppl 1): 159

Trejo, C.; Zhang, J.; Atkinson, C. 1991: Anti transpirant activity in xylem sap. Journal of Experimental Botany 42(238 Suppl): 12

Batra, J.K.; Fitzgerald, D.J.; Chaudhary, V.K.; Pastan, I. 1991: Anti trffv pe40 and dt388 anti trffv single chain immunotoxins directed at the human transferrin receptor containing pseudomonas exotoxin a or diphtheria toxin. Proceedings of the American Association for Cancer Research 32: 271

Hartmann, M.; Dohr, G.; Blaschitz, A.; Haidacher, S.; Desoye, G.; Pilz, G. 1991: Anti trophoblast monoclonal antibody gz 101. Placenta 12(4): 396-397

Gibold, C.; Grulet, H.; Larbre, H.; Delisle, M.J.; Deltour, G. 1989: Anti tsh receptor antibodies assay clinical usefulness for the management of hyperthyroidism in graves disease. European Journal of Nuclear Medicine 15(8): 521

Rugello, D.; Casara, D.; Busnardo, B.; Piccolo, M.; Girelli, M.; Piotto, A.; Pelizzo, M.R. 1992: Anti tsh receptor antibodies tbiabs variations in patients with graves disease gd treated by surgery correlation to residual thyroid function. European Journal of Nuclear Medicine 19(8): 622

Varma, R.K.; Pettit, G.R.; Temple, C.F.Jr; Hamel, E.; Narayanan, V.L. 1992: Anti tumor activities and effects on tubulin polymerization in vitro of water soluble derivatives and pro drugs of combretastatin a 4. Proceedings of the American Association for Cancer Research 33: 517

Pai, L.H.; Fitzgerald, D.J.; Willingham, M.C.; Pastan, I. 1991: Anti tumor activities of immunotoxins made of monoclonal antibody b3 and different forms of pseudomonas exotoxin. Proceedings of the American Association for Cancer Research 32: 261

Double, J.A.; Bibby, M.C.; Matthew, A. 1989: Anti tumor activity and bone marrow toxicity of cnc amino acid derivatives. Investigational New Drugs 7(4): 450

Matthew, A.; Bibby, M.C.; Double, J.A.; Crawford, S.M. 1989: Anti tumor activity and bone marrow toxicity of the tcnu metabolites ls 2724 and ls 2715. Investigational New Drugs 7(4): 450

Bartsch, H.; Bartsch, C. 1991: Anti tumor activity in pineal glands and in urine display similar circannual rhythmicity. Journal of Interdisciplinary Cycle Research 22(2): 89-90

Johnson, D.A.; Gutowski, M.C.; Briggs, S.L.; Fix, D.V.; Henry, A.B. 1989: Anti tumor activity of an anti egf receptor monoclonal antibody and antibody vinca immunoconjugate. Journal of Cellular Biochemistry Suppl (13 Part B): 128

Grandis, J.R.; Chang, M.J.; Furmanski, P.; Braunschweiger, P.G.; Johnson, C.S. 1991: Anti tumor activity of interleukin 1 alpha il 1 plus cisplatin cis ddp against squamous cell carcinomas scc in mice. Proceedings of the American Association for Cancer Research 32: 427

Balassa, L.L.; Prudden, J.F. 1989: Anti tumor agent and method us patent 4822607 april 18 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(3): 1888-1889

Murata, K.; Ebina, T. 1993: Anti tumor effect of a basidiomycetous preparation Differences in induction of serum immunosuppressive acid protein. Japanese Journal of Bacteriology 48(6): 753

Maruyama, H.; Kawamura, H.; Takemoto, N.; Ono, Y.; Hosoya, E. 1990: Anti tumor effect of combination therapy of transplanted meth a fibrosarcoma in balb c mice with surgical excision and a kampo medicine juzentaiho to. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 294

Hann H W.L.; Stahlhut, M.W.; Maddrey, W.C. 1990: Anti tumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice. Hepatology 12(4 Part 2): 912

Gansbacher, B.; Bannerji, R.; Zier, K.; Cronin, K.; Tavorah, R.; Gilboa, E. 1990: Anti tumor effect of gene transfer mediated lymphokine delivery at the tumor site. Journal of Cellular Biochemistry Suppl (14 Part B): 96

Saito, S.; Yoshimura, I.; Heston, W.D.W.; Fair, W.R.; Gilboa, E. 1995: Anti tumor effect of in situ tumor vaccine established by retroviral cytokine gene delivery. Journal of Urology 153(4 Suppl): 520A

Axelrod, H.R.; Hauler, J.A.; Gilman, S.C. 1990: Anti tumor effect of monoclonal antibody b 723 aminopterin hydrazide immunoconjugates on human xenograft growth. Proceedings of the American Association for Cancer Research 31: 288

Silbermann, M.; Nooter, K.; Van Der Meide, P.; Van, D.V.cht B.; Schellekens, H. 1989: Anti tumor effect of rat recombinant interferon gamma alone or in combination with tnf or adriamycin in rats bearing transplantable tumors. Proceedings of the American Association for Cancer Research 30: 388

Scheringa, M.; Keizer, A.; Marquet, R.L.; Jeekel, J. 1989: Anti tumor effect of recombinant murine tnf alpha rmutnfa given by continuous iv infusion as compared to repeated iv injections in a liver metastases model in rats. Investigational New Drugs 7(4): 410

Siegall, C.B.; Fitzgerald, D.J.; Pastan, I. 1990: Anti tumor effects of chimeric toxins comprised of interleukin 6 or transforming growth factor alpha and pseudomonas exotoxin. Proceedings of the American Association for Cancer Research 31: 298

Shinohara, H.; Mizuno D I.; Oshima, H.; Soma G I. 1990: Anti tumor effects of eet exogenous endogenous tnf therapy by histological examination. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 276

Macphee, M.; Friedman, S.; Sayers, T.; Burgess, W.; Maciag, T.; Wiltrout, R.H. 1992: Anti tumor effects of fibroblast growth factor fgf and fgf analogs in vitro and in vivo. Proceedings of the American Association for Cancer Research 33: 76

Neville, M.E. 1990: Anti tumor effects of il 1b inhibition of angiogenesis. Proceedings of the American Association for Cancer Research 31: 294

Neubauer, B.L.; Best, K.L.; Goode, R.L.; Jones, C.D.; Merriman, R.L.; Sarosdy, M.F.; Shaar, C.J.; Tanzer, L.R.; Hirsch, K.S. 1989: Anti tumor effects of ly 117018 in the pa iii rat prostatic adenocarcinoma. Journal of Urology 141(4 Part 2): 501A

Takagi, K.; Fujiyoshi, T.; Takano, M.; Soma G I.; Oshima, H.; Mizuno, D. 1989: Anti tumor efficacy of novel recombinant tumor necrosis factor to metastatic lesions in the liver and local recurrent lesions of colorectal carcinoma. Investigational New Drugs 7(4): 385

Ellenhorn, J.D.I.; Bluestone, J.A. 1989: Anti tumor immunotherapy with anti cd3 monoclonal antibodies induces a tumor specific immune response. Clinical Research 37(2): 408A

Scheringa M.; De Bruin R.W.F.; Heineman E.; Jeekel H.; Marquet R.L. 1992: Anti tumor necrosis factor alpha antibodies prolong allograft survival in rats. Osawa, T And B Bonavida (Ed ) Tumor Necrosis Factor: Structure-Function Relationship And Clinical Application; 3rd International Conference on Tumor Necrosis Factor And Related Cytokines, Makuhari, Japan, November 21-25, 1990 Ix+291p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 262-268

Nelson, S.; Bagby, G.; Summer, W. 1991: Anti tumor necrosis factor alpha antibody suppresses pulmonary antibacterial defenses. American Review of Respiratory Disease 143(4 Part 2): A393

Kisich, K.O.; Erickson, K.L. 1991: Anti tumor necrosis factor alpha ribozymes can specifically cleave tumor necrosis factor alpha messenger rna within mammalian cells. Journal of Leukocyte Biology (Suppl 2): 70

Kisich, K.O.; Erickson, K.I. 1990: Anti tumor necrosis factor alpha ribozymes specifically cleave native messenger rna among total cellular rna in vitro. FASEB Journal 4(7): A1860

Selmai, K.; Cross, A.H.; Raine, C.S. 1991: Anti tumor necrosis factor anti tnf therapy abrogates autoimmune demyelination new therapeutic implications for multiple sclerosis. Journal of Neuroimmunology (Suppl 1): 113

Arii, T.; Morita, M.; Iwasaki, T. 1994: Anti tumor necrosis factor antibody inhibited myocardial slippage at non-infarcted myocardium with acute myocardial infarction. Circulation 90(4 Part 2): I522

Guc, M.O.; Furman, B.L.; Parratt, J.R. 1990: Anti tumor necrosis factor antibody prevents endotoxin induced impairment of vasodepressor responsiveness to 5 hydroxytryptamine. Circulatory Shock 31(2): 232

Lin, H.; Chensue, S.W.; Streiter, R.M.; Bolling, S.F.; Kunkel, S.L. 1991: Anti tumor necrosis factor antibody prolongs heart allograft survival in the rat. FASEB Journal 5(6): A1620

Williams, R.O.; Feldmann, M.; Maini, R.N. 1991: Anti tumor necrosis factor tnf treatment inhibits the progression of established collagen induced arthritis. Arthritis and Rheumatism 34(9 Suppl): S67

Ohigashi, H.; Murakami, A.; Koshimizu, K. 1992: Anti tumor promoters from edible plants. Abstracts of Papers American Chemical Society 204(1-2): AGFD 209

Maeda, H.; Matsumura, Y.; Asami, O.; Tanaka, H.; Sasaki, I. 1989: Anti tumor protease preparations us patent 4844897 july 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(1): 438

Yamamoto, T.; Okada, T.; Abe, M.; Yano, S.; Nakase, A. 1990: Anti tumor response induced by reinfusion of plasma after ex vivo treating with high molar sodium chloride or potassium chloride. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 293

Reid, I.; Lundy, J.; Nelson, H.; Donohue, J. 1991: Anti tumor x anti cd 3 heteroconjugated antibody enhances in vitro tumor lysis by tumor infiltrating lymphocytes. Proceedings of the American Association for Cancer Research 32: 259

Reid, I.; Lundy, J.; Ramsey, P.; Nelson, H.; Donohue, J. 1991: Anti tumor x anti cd3 heteroconjugated antibody enhances in vitro and in vivo tumor lysis in a murine melanoma model. Proceedings of the American Association for Cancer Research 32: 263

Brunton, V.G.; Williamson, S.; Robins, D.; Workman, P. 1992: Anti tumour activity of novel tyrphostins in breast cancer cells. Proceedings of the American Association for Cancer Research 33: 558

Mackay, A.G.; James, S.Y.; Chander, S.; Ofori Kuragu, E.A.; Binderup, L.; Coombes, R.C.; Colston, K.W. 1992: Anti tumour effects of vitamin d analogues. Journal of Endocrinology 132(Suppl)

Durrant, L.G.; Denton, G.W.L.; Robins, R.A. 1991: Anti tumour immune responses induced in colorectal cancer patients by immunization with human monoclonal anti idiotypic antibody. European Journal of Cancer 27(Suppl 3): S75

Lange, C.F.; Kent, S.C. 1990: Anti type 12 streptococcal membrane monoclonal antibody reacts with collagen type iv. FASEB Journal 4(7): A1720

Adabajo, A.O.; Williams, R.O.; Williams, D.G.; Hazleman, B.L.; Maini, R.N. 1992: Anti type ii collagen and anti keratin antibodies in the rheumatoid arthritis population of west africa. British Journal of Rheumatology 31(Suppl 1): 8

Wilkinson, K.D.; Brown, K.M. 1991: Anti ubiquitin immunoreactivity the effects of antibody variability on the types and amounts of stable conjugates detected in subcellular fractions from hepatocytes. FASEB Journal 5(5): A1179

Kuwayama, H.; Takeuchi, K. 1989: Anti ulcer and cytoprotective properties of z 103 n 3 aminopropionyl l histidine zinc in the rat. Japanese Journal of Pharmacology 49(Suppl): 120P

Ivanova N.S.; Ivanov T.B.; Dryanska M.D.; Zabunova O.B.; Dalleva L.D.; Nikolova M.P.; Berova N.D.; Rakovska R.S.; Stoyanova M.S.; Et Al 1989: Anti ulcer composition us patent 4806548 february 21 1989. Official Gazette of the United States Patent and Trademark Office Patents 1099(3): 1484

Hosoi, M.; Nishioka, R.; Hioki, Y.; IIda, Y.; Takeshita, H.; Niiyama, K.; Hidaka, Y. 1989: Anti ulcer substituted pyridine derivatives us patent 4839353 june 13 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(2): 1251

Murali, M.R.; Durkin, H.G.; Auci, D.L. 1991: Anti urokinase uk antibody but not anti tissue type plasminogen activator tpa antibody or uk alone augments phytohemagglutinin pha induced proliferative responses pr of human peripheral blood lymphomononuclear cells mnc. Journal of Allergy and Clinical Immunology 87(1 Part 2): 284

Vanderborght B.; Deleys R.J.; De Sa C.A.M.; Santos E.A.; Cassaita R.M.; Alcantara V.G.; Sion F.S.; Bonecini M.G.; Van Heuverswyn H. 1992: Anti v3 loop reactivity in hiv 1 infected patients in rio de janeiro brazil. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : a30

Wong, J.T.; Curiel, T.J.; Schooley, R.T.; Walker, B.D. 1991: Anti viral activities of preferentially propagated cd4 plus and cd8 positive t cell subsets from hiv infected subjects. Journal of Allergy and Clinical Immunology 87(1 Part 2): 316

French, C.J.; Ibrahim, R.K.; Towers, G.H.N. 1990: Anti viral activity of methylated flavonoids against tobacco mosaic virus. Canadian Journal of Plant Pathology 12(3): 334

Marcellin, P.; Samuel, D.; Loriot, M.A.; Areias, J.; Bismuth, H.; Benhamou, J.P. 1990: Anti viral effect of adenine arabinoside monophosphate ara amp in patients with recurrence of hepatitis b virus hbv infection after liver transplantation. Hepatology 12(4 Part 2): 966

Srinivas, R.V.; Birkedal, B.; Owens, R.J.; Segrest, J.P.; Anantharamaiah, G.M.; Compans, R.W. 1989: Anti viral effects of apolipoprotein a i and its peptide analogs. Journal of Dental Research 68(Special Issue): 305

Ashton, W.T.; Field, A.K.; Karkas, J.D.; Tolman, R.L. 1989: Anti viral guanine compounds us patent 4816447 march 28 1989. Official Gazette of the United States Patent and Trademark Office Patents 1100(4): 2418

Ogilvie, K.K. 1989: Anti viral n substituted pyrimidines us patent 4868187 september 19 1989. Official Gazette of the United States Patent and Trademark Office Patents 1106(3): 1973-1974

Clark, W.; Walsh, C.; Fernandez, K. 1990: Anti viral peptides produced by ctls. FASEB Journal 4(7): A1706

Imani, F.; Everest, A.R.; Jacobs, B.L.; Proud, D.; Marsh, D.G. 1998: Anti viral protein kinase modulates expression of Th2-type responses. FASEB Journal 12(5): A1056

Easty D.L.; Menage M.J.; De Clercq E.; Van Lierde A.; Easty V.S.; Darville J.M.; Cook S.D. 1989: Anti viral sensitivity in ocular herpes simplex infection. IOVS Investigative Ophthalmology and Visual Science 30(3): 362

Holland, K.; Saral, R. 1992: Anti viral therapy and allogeneic bone marrow transplantation bmt for hiv 1 related malignancies. Journal of Cellular Biochemistry Suppl (16 Part A): 180

Ruprecht, R.M.; Mullaney, S.; Sosa, M.G.; Hom, R.; Finberg, R. 1989: Anti viral therapy induces t cells which protect against viral challenge. Diamond, L And S R Wolman (Ed ) Annals Of The New York Academy Of Sciences, Vol 567 Viral Oncogenesis And Cell Differentiation: The Contributions Of Charlotte Friend; Conference, New York, New York, Usa, September 29-October 1, 1988 Ix+356p New York Academy Of Sciences: New York, New York, Usa Illus 344-346

Kaul, D.K.; Sussman, I.I.; Tsai, H.M.; Nagel, R.L. 1989: Anti von willebrand factor antibodies inhibit and desmopressin enhances adhesion of ss cells to the endothelium in flow conditions. Clinical Research 37(2): 546A

D.M.at M.P.M.; Knot, E.A.R. 1990: Anti xa activity levels with a new assay measuring heparin bound to platelet factor 4. Fibrinolysis 4(Suppl 3): 51

Peterson, K.; Kotanides, H.; Furneaux, H.M.; Posner, J.B. 1991: Anti yo positive paraneoplastic cerebellar degeneration a clinical study of 51 patients. Neurology 41(3 Suppl 1): 362

Ireland, J.H.; Hsia, Y.E.; Chui, D.H.K. 1991: Anti zeta screening for alpha 1 thalassemias. Clinical Research 39(2): 429A

Ireland, J.H.; Hsia, Y.E.; Chui, D.H.K. 1991: Anti zeta screening for double deletion alpha thalassemias. Clinical Research 39(1): 33A

Ireland, J.H.; Hsia, Y.E.; Chui, D.H.K. 1991: Anti zeta testing for alpha 1 thalassemia in newborns. Pediatric Research 29(4 Part 2): 143A

Ireland, J.H.; Hsia, Y.E.; Chu, B.M.; Chui, D.H.K. 1991: Anti zeta will reliably detect sea double alpha deletions. American Journal of Human Genetics 49(4 Suppl): 329

Kamada, M.; Daito, T.; Aono, T. 1992: Anti zona pellucida antibodies. Clinical Gynecology and Obstetrics 46(2): 184-185

Lau, Chi Chi; Du Clos, Terry W. 1997: Anti- -DNA antibodies in patients receiving procainamide. Arthritis and Rheumatism 40(9 Suppl): S84

Huntley, C.C.; Costas, M.C.; Williams, R.C.; Lyerly, A.D.; Glenn Watson, R. 1966: Anti- -globulin factors in visceral larva migrans. J American Medicine Association 197(7): 552-556

Hestrin, S. 1940: Anti- -glucosidas. Biochem Jour 34(2): 213-220

Ottesooser, F. 1958: Anti- N plant agglutinins their origin, preparation and controL. Anais da Academia Brasileira de Ciencias 30(1): 65-73

Quinton, J.F.; Sendid, B.; Reumaux, D.; Cortot, A.; Poulain, D.; Colombel, J.F. 1997: Anti- Saccharomyces cerevisiae antibodies combined with anti neutrophil antibodies differentiate Crohns disease from ulcerative colitis. Gastroenterology 112(4 Suppl): A1066

Chekhonin, V.; Kabanov, A.; Rjabukhin, I.; Dmitrieva, T. 1998: Anti- alpha2-GP and anti-GFAP antibodies as the vectors for targeted delivery daunomycin into the rat glioma. Tumor Biology 19(Suppl 2): 82

Cotter, M.A.; Cameron, N.E.; Archibald, V. 1993: Anti- and pro-oxidant effects on nerve conduction velocity in diabetic and non-diabetic rats. Diabetologia 36(Suppl 1): A198

Cameron, N.E.; Cotter, M.A.; Archibald, V.; Dines, K.C. 1994: Anti- and pro-oxidant effects on peripheral nerve perfusion and conduction velocity in diabetic and non-diabetic rats. Journal of Physiology (Cambridge) 477P: 36P

Chignell, C.F. 1997: Anti- and prooxidant properties of melatonin and related indoles. Photochemistry and Photobiology 65(SPEC ISSUE): 16S

Virtanen, A.I. 1958: Anti- microbial substances in our cultivated plants and their importance to the plants and to human and animal nutrition. Schweiz Zeitschr Allg Path U Bakt 21(5): 970-993

Kondrat' Ev, N.P. 1967: Anti- shock action of the polyvitamln liquid. Vestn Khir I I Grekova 99(12): 18-22

Barnes, J.M. 1959: Antitoxin transfer from mother to foetus in the guinea-pig. Journal of Pathology and Bacteriology 77(2): 371-380

Wiemer 1927: Anti-0 agglutinin in human blood. Deutsch Arch Klin Med 156(5/6): 305-311

Yanagi, K.; Ishimaru, N.; Haneji, N.; Saegusa, K.; Saito, I.; Hayashi, Y. 1998: Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome. European Journal of Immunology 28(10): 3336-3345

Colmegna, Iés.; Sainz, B.; Citera, G.; Maldonado-Cocco, J.A.; Garry, R.F.; Espinoza, L.R. 2008: Anti-20S proteasome antibodies in psoriatic arthritis. Journal of Rheumatology 35(4): 674-676

Cozzani, E.; Micalizzi, C.; Parodi, A.; Rebora, A. 1997: Anti-230 kDa circulating IgE in bullous pemphigoid: relationship with disease activity. Acta Dermato-Venereologica 77(3): 236

Genovese, S.; Bonifacio, E.; Bingley, P.J.; Christie, M.R.; Bonfanti, R.; Shattock, M.; Fonte, M.T.; Bottazzo, G.F.; Gale, E.A.M. 1993: Anti-37K are specific markers for type 1 diabetes in ICA positive school children. Diabetologia 36(Suppl 1): A98

Gelpi, C.; Alguero, A.; Diaz, C.; Martinez, M.A.; Rodriguez Sanchez, J.L. 1992: Anti-42KDa protein A new anti-nuclear antibody specificity. Arthritis and Rheumatism 35(9 Suppl): S302

Sasson, M.; Stiller, M.; Shupack, J.; Karkoszka, J.; Khasak, D.; Frenkel, K. 1993: Anti-5-hydroxymethyl-2-deoxyuridine antibody titers in patients with inflammatory dermatoses are altered by systemic therapy. Journal of Investigative Dermatology 100(4): 577

Hiriyakkanavar, J.G.; Siddappa, S.; Sirsi, M. 1965: Anti-5-Hydroxytryptamine Activity of some Substituted Tryptamines. Indian Journal of Experimental Biology 3: 56-58

Mccauliffe, D.P.; Wang, L.; Satoh, M.; Reeves, W.; Small, D. 1997: Anti-52 kD Ro autoantibodies go undetected by conventional Ro serologic assays. Journal of Investigative Dermatology 108(4): 640

Doerner, T.; Feist, E.; Wagenmann, A.; Kato, T.; Yamamoto, K.; Nishioka, K.; Burmester, G.R.; Hiepe, F. 1994: Anti-52 kD Ro autoantibodies occurring in different autoimmune diseases preferentially recognize a B-cell epitope present on the central region of the antigen. Arthritis and Rheumatism 37(9 Suppl): S172

Takasaki, Y.; Hirokawa, K.; Yamanaka, K.; Hashimoto, H.; Hirose, S.I.; Chan, E.K.L. 1992: Anti-52 kD SS-A antibodies in MCTD patients with sicca syndrome. Arthritis and Rheumatism 35(9 Suppl): S302

Conlon, K.A.; Grollman, A.P.; Berrios, M. 1998: Anti-8-oxoguanine antibodies reveal that relatively mild cellular stress induces oxidative DNA damage. Proceedings of the American Association for Cancer Research 39: 490

Ottensooser, F.; Sato, M. 1964: Anti-A + B in Phaseolus vulgaris and other plants. Anais da Academia Brasileira de Ciencias 36(2): 199-205

Juel, E. 1959: Anti-A agglutinins in sera from A2B individuals. Acta Pathologica et Microbiologica Scandinavica 46(1): 91-95

Rutzky, J.; Cohen, F.; Zuelzer, W.W. 1956: Anti-A agglutinins in pooled plasma as a cause of hemolytic anemia. Blood 11(5): 403-422

Mizan, N. 1961: Anti-A agglutinins in the A2B blood groups. Turkish Bull Hyg And Exptl Biol 21(3): 203-206

Bouton, P. 1951: Anti-A and -B hemagglutinins in mothers milk Their role in the pathology of the newborn. Ann Inst Pasteur Lille: 144

Novachenko, T.M. 1960: Anti-A and anti-B iso-immune antibodies and their role in blood transfusion and in pregnancy Problemy Gematol. I Perel Krovi Transl J 5(2): 110-117

Brendemoen, O.J.; Brendemoen, C. 1948: Anti-A and anti-B isoagglutinin titers in Rh-immunized pregnant women. Journal of Laboratory and Clinical Medicine 33(9): 1089-1093

Bird, G.W.G. 1952: Anti-A haemagglutinins in seeds. Journal of Immunology 69(3): 319-320

Walker, C.B.; Dennis, H.G. 1959: Anti-A Haemolysin in Group O Blood Donors. British Medical Journal 2(5162): 1303-1305

Lee, J.H.; Lee, K.H.; Kim, S.; Lee, J.S.; Kwon, S.W.; Kim, W.K.; Kim, S.H. 1998: Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia complicating major ABO-incompatible allogeneic BMT. Blood 92(10 Suppl 1 Part 1-2): 134A

Filitti Wurmser, S.; Jacquot Armand, Y.; Theoleyre, M. 1958: Anti-A isohaemagglutinins occurring naturally and provoked by immunisation. REV HEMATOL 13-13(1): 295-304, No 1162

Sachs, V. 1967: Anti-A und Anti-A1 im Serum einer gesunden Schwangeren der Blutgruppe AB mit sehr schwachem A-Anteil. Z Immuni Tatsforsch Allergie Klin Immunol: 129-137

Brilliantine, L.; Aranda, L.H.; Foster, D.M.; Allen, N.K. 1964: Anti-A1 Specific Lectin from a Central American Leguminous Plant. Journal of Immunology 92: 555-558

Steiner, G.; Skriner, K.; Plows, D.; Kollias, G.; Cohen, P.; Klareskog, L.; Smolen, J.S. 1997: Anti-A2/RA33 autoantibodies in animal models of rheumatoid arthritis and SLE. Arthritis and Rheumatism 40(9 Suppl): S56

Richardson, R.; Ruff, R.L. 1998: Anti-AChR antibodies in passively transferred autoimmune myasthenia gravis reduce endplate sodium currents by decreasing the density of endplate sodium channels not by blocking sodium channels. Neurology 50(4 Suppl 4): A433

Suzuki, M.; Yu, D.; Morris-Natschke, S.L.; Smith, P.C.; Lee, K.-H. 2007: Anti-AIDS agents 66: syntheses and anti-HIV activity of phenolic and aza 3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) derivatives. Bioorganic and Medicinal Chemistry 15(21): 6852-6858

Takeuchi, Y.; Xie, L.; Cosentino, L.M.; Lee, K.H. 1997: Anti-AIDS agents XXVIII Synthesis and anti-HIV activity of methoxy substituted 3,4-di- -camphanoyl- -cis-khellactone analogues. Bioorganic and Medicinal Chemistry Letters 7(20): 2573-2578

Kitto, G.B. 1997: Anti-AIDS immunotoxins. Official Gazette of the United States Patent and Trademark Office Patents 1200(2): 1201

Palmer, J.R.; Aristoff, P.A.; Romero, D.L. 1996: Anti-AIDS piperazines. Official Gazette of the United States Patent and Trademark Office Patents 1183(1): 280-281

Estey, E. 1997: Anti-AML chemotherapy in high-risk MDS The MD Anderson Cancer Center experience. Leukemia Research 21(Suppl 1): S45

Yokoyama, M.; Stegmaier, A.; Epstein, W.L. 1967: Anti-Ap1 and Anti-Bi antibodies in immune human sera. Zeitschrift für Immunitatsforschung Allergie und Klinische Immunologie 132(1): 1-11

Sho, Y.; Miyazaki, H.; Komorizono, Y.; Yamasaki, N.; Hiwaki, T.; Yamauchi, K.; Takeuchi, I.; Sakurai, K.; Oketani, M.; Ishibashi, K.; Arima, T. 1996: Anti-AR142, an anti-core antibody test, is an accurate assessment of interferon therapy for patients with chronic hepatitis C. Hepatology 24(4 Part 2): 157A

Treichel, U.; Seki, T.; Mcfarlane, B.M.; Freni, M.A.; Gerken, G.; Kyosawa, K.; Stickel, F.; Furuta, F.; Mcfarlane, I.G.; Meyer Zum Bueschenfelde, K.H. 1993: Anti-ASGPR autoantibodies Close linkage with autoimmune hepatitis in Japanese and European patients. Journal of Hepatology 18(Suppl 1): S82

Geserick, G.; Dufková, J. 1967: Anti-Ag (b,x) after 217 transfusions. Zeitschrift für Immunitatsforschung Allergie und Klinische Immunologie 132(1): 62-71

Amino, H.; Saito, H.; Nishiyama, N. 1996: Anti-Apoptotic impact of ATP and adenosine in the cultured rat cerebellar granule cells. Society for Neuroscience Abstracts 22(1-3): 1485

Hefferan Kevin, P.; Admou Hassan; Karson Jeffrey, A.; Saquaque Ali 2000: Anti-Atlas Morocco role in Neoproterozoic western Gondwana reconstruction. Precambrian Research 103(1-2): 89-96

Faure Muret, A. 1971: Anti-Atlas, Morocco. Earth Science = Sciences de la Terre 6: 163-175

Blakely, M.L.; Van der Werf, W.J.; Dalmasso, A.P.; Bach, F.H. 1994: Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts. Transplantation Proceedings 26(3): 1374-1375

Berti, E.; Paulli, M.; Marzano, A.; Boveri, E.; Roscetti, E.; Crosti, L. 1993: Anti-B cell panel reactivity on lymphoid tissues and B-cell lymphomas. Tissue Antigens 42(4): 301

Benkerrou, M.; Jais, J.P.; Leblond, V.; Durandy, A.; Sutton, L.; Bordigoni, P.; Garnier, J.L.; Le Bidois, J.; Le Deist, F.; Blanche, S.; Fischer, A. 1998: Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood 92(9): 3137-3147

Spanier, T.B.; Choudhri, A.F.; Rose, E.A.; Oz, M.C.; Schmidt, A.M. 1997: Anti-B1-adrenoceptor autoantibodies A marker of ventricular recovery in patients with left ventricular assist devices. Journal of Heart and Lung Transplantation 16(1): 80

Clark Soloninka, C.A.; Bruce, I.N.; Spitzer, K.A.; Nadler, J.; Laskin, C.A. 1998: Anti-B2 glycoprotein I and anti-cardiolipin antibodies distinguish clinical subsets within the anti-phospholipid antibody syndrome. Arthritis and Rheumatism 41(9 Suppl): S168

Lee, R.M.; Emlen, W.; Branch, D.W.; Scott, J.R.; Silver, R.M. 1998: Anti-B2-glycoprotein-I antibodies are not associated with recurrent pregnancy loss, unexplained fetal death, or antiphospholipid syndrome. American Journal of Obstetrics and Gynecology 178(1 Part 2): S101

O'connor, R.; Liu, C.; Teicher, B.A.; Shah, S.A.; Blattler, W.A. 1993: Anti-B4 blocked ricin as a candidate to reverse multidrug-resistance in B cell tumors. Blood 82(10 Suppl 1): 140A

Szatrowski, T.P.; Larson, R.A.; George, S.; Dodge, R.; Hurd, D.; Kolitz, J.; Velez Garcia, E.; Sklar, J.; Reynolds, C.; Westbrook, C.A.; Frankel, S.W.; Stewart, C.; Bloomfield, C.D.; Schiffer, C.A. 1995: Anti-B4-blocked ricin as consolidation therapy for patients with B-lineage acute lymphoblastic leukemia A phase II trial. Blood 86(10 Suppl 1): 783A

Grossbard, M.L.; O'day, S.; Gribben, J.G.; Freedman, A.S.; Rabinowe, S.N.; Neuberg, D.; Esseltine, D.L.; Epstein, C.L.; Nadler, L.M. 1993: Anti-B4-blocked ricin therapy following autologous bone marrow transplantation for B-cell non-Hodgkins lymphoma Update of phase I/II trials. Blood 82(10 Suppl 1): 444A

Lopez Longo, F.J.; Rodriguez Mahou, M.; Gonzalez, C.; Perez, T.; Moreno, A.C.; Sanchez, A.I.; Grau, R.; Escalona, M.; Monteagudo, I.; Carreno, L. 1993: Anti-BB-Sm antibodies, anticardiolipin and thrombotic events in systemic lupus erythematosus. Arthritis and Rheumatism 36(9 Suppl): S273

Randhawa, P.; Zemlicka, J.; Sauerbrei, A.; Meier, C.; Hostetler, K.Y.; Beadle, J.R.; Farasati, N.A.; Huang, Y.; Bradley, M. 2008: Anti-BK virus activity of nucleoside analogs. Antimicrobial Agents and ChemoTherapy 52(4): 1519-1521

Cohen, P.; Pasqualucci, L.; Butmarc, J.; Kadin, M. 1994: Anti-BLA36 expression in anaplastic large cell lymphomas and lymphomatoid papulosis of primarily T cell origin. Modern Pathology 7(1): 105A

Elzouki, A.N.; Eriksson, S.; Lofberg, R.; Wieslander, J.; Lindgren, S. 1998: Anti-BPI antibodies and alpha1-antitrypsin deficiency state in patients with ulcerative colitis Prevalence and clinical correlation. Clinical and Experimental Immunology 112(Suppl 1): 20

Lin, W.Yu.; Gong, Q.; Seshasayee, D.; Lin, Z.; Ou, Q.; Ye, S.; Suto, E.; Shu, J.; Lee, W.Pun.; Lee, C-Wei.V.; Fuh, G.; Leabman, M.; Iyer, S.; Howell, K.; Gelzleichter, T.; Beyer, J.; Danilenko, D.; Yeh, S.; DeForge, L.E.; Ebens, A.; Thompson, J.S.; Ambrose, C.; Balazs, M.; Starovasnik, M.A.; Martin, F. 2007: Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade. Blood 110(12): 3959-3967

Izar, G. 1926: Anti-Bang and anti-Bruce agglutinin. Bol Soc Biol Sperim 1(3): 273-275

Kaspin, L.C.; Baird, W.M. 1995: Anti-Benzo pyrene-7,8-diol-9, 10-epoxide treatment increases p53 protein levels in the human mammary carcinoma cell line MCF-7. Proceedings of the American Association for Cancer Research 36: 158

Davies, K.A.; Norsworthy, P.J.; Athanassiou, P.; Walport, M.J. 1997: Anti-C1q antibodies activate complement and may be pathogenic in SLE. Arthritis and Rheumatism 40(9 Suppl): S308

Davies, K.A.; Norsworthy, P.; Walport, M.J. 1995: Anti-C1q antibodies are associated with hypo-complementaemia, defective opsonisation of gram-positive organisms, and death due to infection in patients with SLE. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 613

Jacobson, S.H.V.an Gunnarsson; Lundberg, I.; Klareskog, L. 1996: Anti-C1q antibodies in IgA nephropathy , membranous nephropathy and SLE nephritis. Journal of the American Society of Nephrology 7(9): 1774

Zhou, Y.; Gong, B.; Lin, F.; Rother, R.P.; Medof, M.Edward.; Kaminski, H.J. 2007: Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia gravis. Journal of Immunology 179(12): 8562-8567

Rollin, S.A.; Fitch, J.C.K.; Shernan, S.; Rinder, C.S.; Rinder, H.M.; Smith, B.R.; Collard, C.D.; Stahl, G.L.; Alford, B.L.; Li, L.; Matis, L.A. 1998: Anti-C5 single chain antibody therapy blocks complement and leukocyte activation and reduces myocardial tissue damage in CPB patients. Molecular Immunology 35(6-7): 397

Ember, J.A.; Morgan, E.L.; Sanderson, S.D.; Hugli, T.E. 1994: Anti-C5a receptor antibody inhibits biologic activity of C5a but not synthetic C5a analogues. FASEB Journal 8(4-5): A500

Su, B.; Montel, A.; Morse, P.; Brahmi, Z. 1992: Anti-C9 antibodies inhibit lysis mediated by cytotoxic lymphocytes and by granule extracts. Natural Immunity 11(5): 301-302

Rhodes, B.A.; Wall, F.; Raud, J. 1995: Anti-CD 15 Binding to Human Neutrophils. Journal of Nuclear Medicine 36(5 Suppl): 156P

Wang, X.H.; Xie, T. 1993: Anti-CD3 and -CD4 monoclonal antibody in the treatment of steroid-resistant renal allograft rejection. Chinese Medical Journal 106(11): 821-824

Merritt, W.D.; Der Minassian, V. 1994: Anti-CD-3-stimulated tyrosine phosphoprotein expression in GD-3+ Jurkat cells. Molecular Biology of the Cell 5(Suppl ): 11A

L.M.uff, B.; Hourmant, M.; Soulillou, J.P. 1993: Anti-CD11a mAb in immunointervention. European Surgical Research 25(6): 408

Chopp, M.; Zhang, R.L.; Chen, H.; Bodzin, G.; Rusche, J.R. 1994: Anti-CD11b monoclonal antibody reduces infarct size resulting from transient but not permanent focal ischemia in rat. Stroke 25(1): 267

Sun, X.M.; Granger, D.N.; Hsueh, W. 1994: Anti-CD11b/CD18 prevents PAF-induced intestinal injury in rats. FASEB Journal 8(4-5): A134

Bochsler, P.N.; Yang, Z.; Miller, M.S.; Breider, M.A. 1994: Anti-CD14 monoclonal antibody inhibits bovine serum dependent tissue factor expression and cytotoxicity in bovine vascular endothelial cells. FASEB Journal 8(4-5): A316

Allina, J.; Stanca, C.M.; Garber, J.; Hu, B.; Sautes-Fridman, C.; Bach, N.; Odin, J.A. 2008: Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis. Journal of Autoimmunity 30(4): 238-245

Ida, H.; Eguchi, K.; Mizokami, A.; Yamashita, I.; Origuchi, T.; Shimada, H.; Kawabe, Y.; Nagataki, S. 1993: Anti-CD18 and anti-ICAM-3 monoclonal antibodies blocked the human T-cell lymphotropic virus type I -induced syncytium formation. Tissue Antigens 42(4): 286

Chopp, M.; Zhang, R. 1998: Anti-CD18 antibody enhances the therapeutic efficacy for thrombolysis in rats. European Journal of Neurology 5(Suppl 1): S31

Tanaka, K.; Dever, L.; Factor, S.; Wright, S.; Tomasz, A. 1994: Anti-CD18 antibody prevents polymorphonuclear cell diapedesis but not margination induced by pneumococcal cell wall in the rabbit model of meningitis. Modern Pathology 7(1): 145A

Bautista, A.P.; Spolarics, Z.; Jaeschke, H.; Smith, C.W.; Spitzer, J.J. 1992: Anti-CD18 antibody stimulates and primes the Kupffer cells to release interleukin-1 and tumor necrosis factor. Journal of Leukocyte Biology 1992(Suppl 3): 15

Stanciu-Herrera, C.; Morgan, C.; Herrera, L. 2008: Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines. Leukemia Research 32(4): 625-632

Woodward, J.; Baliga, P.; Qin, L.; Chavin, K.; Lin, J.; Ding, Y.; Linsley, P.; Bromberg, J. 1994: Anti-CD2 MAb plus CTLA4Ig alter cytokine and cytokine receptor expression. Journal of Leukocyte Biology 1994(Suppl ): 20

Chavin, K.D.; Bromberg, J.S. 1992: Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival and decrease the associated cytokine syndrome. Surgical Forum 43: 391-392

Lee, C.K.; Hayashi, M.; Harman, G.S.; Hohl, R.J.; Ajram, K.A.; Gingrich, R.D. 1995: Anti-CD2 cell depletion with two level T cell addback in allogeneic bone marrow transplantation. Blood 86(10 Suppl 1): 570A

Chavin, K.D.; Qin, L.; Lin, J.; Kaplan, A.J.; Bromberg, J.S. 1993: Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production. Transplantation Proceedings 25(1 Part 1): 823-824

Schad, V.; Maher, M.; Kolber, D.; Giovino Barry, V.; Leguern, A.; Xu, Y.; White Scharf, M.E.; Bazin, H.; Latinne, D. 1996: Anti-CD2 monoclonal antibody elicits specific alloantigen hyporesponsiveness. FASEB Journal 10(6): A1313

Chavin, K.D.; Qin, L.; Lin, J.; Kaplan, A.J.; Bromberg, J.S. 1992: Anti-CD2 monoclonal antibody suppresses cytotoxic T lymphocyte generation in vivo and in vitro. Journal of Leukocyte Biology 1992(Suppl 3): 26

Bromberg, J.S.; Qin, L.; Lin, J.; Chavin, K.D. 1993: Anti-CD2 monoclonal antibody suppresses the generation of cytotoxic T lymphocyte in vivo and in vitro. Journal of Immunology 150(8 Part 2): 279A

Gray, J.D.; Ohtsuka, K.; Hirokawa, M.; Horwitz, D.A. 1996: Anti-CD2 stimulation of an inhibitory circuit dependent on TGF-beta. FASEB Journal 10(6): A1486

Chabanillas, F.; Grillo Lopez, A.J.; Mclaughlin, P.; Link, B.K.; Levy, R.; Czucman, M.; Heyman, M.R.; Williams, M.; Jain, Y.; Bence Bruckler, L.; Ho, A.D.; Lister, J.; Rogers, J.; Shen, D.; Varns, C. 1996: Anti-CD20 antibody , IDEC-C2B8 Clearance of bcl-2 t positive cells from peripheral blood and bone marrow in patients with relapsed low-grade or follicular lymphoma. Blood 88(10 Suppl 1 Part 1-2): 91A

Mathas, S.; Bommert, K.; Doerken, B.; Mapara, M.Y. 1998: Anti-CD20 antibody IDEC-C2B8 mediated apoptosis can be blocked by inhibition of caspase 3. Experimental Hematology 26(8): 726

Mathas, S.; Bommert, K.; Dorken, B.; Mapara, M.Y. 1998: Anti-CD20 antibody IDEC-C2B8 mediated apoptosis is dependent on caspase 3 activation. Annals of Hematology 77(Suppl 2): S17

Mathas, S.; Bommert, K.; Doerken, B.; Mapara, M.Y. 1998: Anti-CD20 antibody mediated apoptosis is dependent on caspase 3 activation. Blood 92(10 Suppl 1 Part 1-2): 405A

Grillo Lopez, A.J.; Dallaire, B.K.; Varns, C.; Leonard, J.E.; Shen, D.; Mcclure, A.; Rogers, J.; Rosenberg, J.; Wei, A.; Shuey, S. 1996: Anti-CD20 chimeric antibody, IDEC-C2B8 Safety and clinical activity in the treatment of relapsed low grade or follicular lymphomas. Experimental Hematology 24(9): 1150

Faye, A.; Van Den Abeele, T.; Peuchmaur, M.; Mathieu-Boue, A.; Vilmer, E. 1998: Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders. Lancet 352(9136): 1285

Cacoub, P.; Delluc, A.; Saadoun, D.; Landau, D.A.; Sene, D. 2008: Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?. Annals of the Rheumatic Diseases 67(3): 283-287

Kapoor, P.; Greipp, P.T.; Morice, W.G.; Rajkumar, S.V.; Witzig, T.E.; Greipp, P.R. 2008: Anti-CD20 monoclonal antibody therapy in multiple myeloma. British Journal of Haematology 141(2): 135-148

Simon, D.; Hösli, S.; Kostylina, G.; Yawalkar, N.; Simon, H.-U. 2008: Anti-CD20 (rituximab) treatment improves atopic eczema. Journal of Allergy and Clinical Immunology 121(1): 122-128

Roll, P.; Dörner, T.; Tony, H-Peter. 2008: Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment. Arthritis and Rheumatism 58(6): 1566-1575

Mahmoud, H.; Brenner, M.; Rooney, C.; Heslop, H.; Krance, R. 1993: Anti-CD21 and CD24 monoclonal antibody therapy for B-cell lymphoproliferative disease following bone marrow transplantation. Blood 82(10 Suppl 1): 636A

Pan, H.; Lu, H.M.; Hu, W-M.; Tian, B-L.; Liu, X-B.; Zhang, Z-D.; Mai, G. 2007: Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation. Transplantation Proceedings 39(10): 3452-3454

Clark, G.; Amlot, P. 1995: Anti-CD25 monoclonal antibody induces remission of steroid responsive nephrotic syndrome A case report. Pediatric Nephrology 9(6): C86

Guillonneau, C.; Séveno, Céline.; Dugast, A-Sophie.; Li, X-Liang.; Renaudin, K.; Haspot, F.; Usal, C.; Veziers, Jëlle.; Anegon, I.; Vanhove, B. 2007: Anti-CD28 antibodies modify regulatory mechanisms and reinforce tolerance in CD40Ig-treated heart allograft recipients. Journal of Immunology 179(12): 8164-8171

June, C.H.; Levine, B.L.; Ueda, Y.; Craighead, N.; Huang, M.J. 1995: Anti-CD28 antibody and ligands CD80 and CD86 induce distinct patterns of cytokine secretion and maintain long term autocrine growth of CD4+ T cells. Journal of Cellular Biochemistry Suppl 1995(21A): 121

Kaye, P.M.; Gorak, P.; Murphy, M.; Perrin, P.J.; June, C.H. 1995: Anti-CD28 immunotherapy in murine visceral leishmaniasis. Journal of Cellular Biochemistry Suppl 1995(21A): 171

Townsend, M.F.; Wang, Y.C.; Hillyer, C.D.; Ansari, A.A.; GrahamSam, D.Jr.; Dillehay, D.D.; Mosunjac, M.; Selvaraj, P.; Petros, J.A.; Keane, T.E.; Sell, K.W. 1995: Anti-CD28 mAB and IL-2 provide costimulatory signals for human T cell sensitization to autologous renal cell carcinoma in vitro. Journal of Urology 153(4 Suppl): 403A

Henrickson, M.; Giannini, E.; Hirsch, R. 1993: Anti-CD3 F -2 fragments delay expansion of alpha-beta-positive CD4-negative CD8-negative B220-positive cells in the MRL/lpr murine model of autoimmunity. Journal of Immunology 150(8 Part 2): 80A

Lee, C.K.; Gingrich, R.D.; Harman, G.S.; Hohl, R.J.; Ajram, K.A.; Padley, D.J.; Huling, D.A.; Trigg, M.E. 1995: Anti-CD3 T cell depletion and add-back Comparative analysis with anti-CD2 TCD-AB in allogeneic bone marrow transplantation. Blood 86(10 Suppl 1): 570A

Wang, Z.; Lu, P.; Weiner, G.J.; Tso, J.; Negrin, R.S. 1996: Anti-CD3 X anti-1D10 bispecific antibody retargets and enhances the cytotoxicity of cytokine induced killer cells. Blood 88(10 Suppl 1 Part 1-2): 316A

Chapoval, A.I.; Thibault, C.; Nelson, H. 1995: Anti-CD3 X antitumor bifunctional antibodies induce cytotoxicity in tumor infiltrating lymphocytes. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 875

Klaus, S.J.; Armitage, R.J.; Fanslow, W.C.; Grabstein, K.H.; Clark, E.A. 1993: Anti-CD3 activated human T cells stimulate B cell growth via CD40 dependent and independent pathways. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 174

Maclean, J.A.; Auchincloss, H.; Su, Z.; Wong, J.T. 1993: Anti-CD3 anti-CD25 bispecific monoclonal antibody Targeting of activated T cells and prolongation of skin allograft. Journal of Allergy and Clinical Immunology 91(1 Part 2): 215

Chatenoud, L.; Bach, J.F. 1993: Anti-CD3 antibodies. Immunology Series 59: 175-191

Frangoul, H.A.; Lin, M.T.; Carpenter, P.; Gooley, T.; Tso, J.Y.; Anasetti, C.; Hansen, J.A. 1998: Anti-CD3 antibody HuM291 induces peripheral T cell apoptosis in patients with acute graft versus host disease following allogeneic hematopoietic cell transplantation. Blood 92(10 Suppl 1 Part 1-2): 448A

Burger, R.A.; Torres, A.R.; Warren, R.P.; Spendlove, R. 1993: Anti-CD3 antibody activation on tumor infiltrating lymphocytes cultured in lymphocyte culture fluid. FASEB Journal 7(3-4): A369

Bolton, W.E.; Maples, J.A.; Siiman, O.; Kenyon, N.S.; Healy, C.G. 1996: Anti-CD3 antibody-aminodextran conjugates for induction of T-cell activation and proliferation. Official Gazette of the United States Patent and Trademark Office Patents 1187(3): 2002

Gantner, F.; Jilg, S.; Tiegs, G. 1994: Anti-CD3 antibody-induced liver injury in D-galactosamine sensitized mice is mediated by TNF. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R66

Neumann, C.M.; Oughton, J.; Kerkvliet, N.I. 1995: Anti-CD3 as a model to assess the effects of xenobiotics on T-cell activation in vivo. Burleson, G R, Dean, J H, Munson, A E Methods in immunotoxicology, Vols 1 and 2 173-188

Mandel, T.E.; Koulmanda, M. 1992: Anti-CD3 monoclonal antibody prolongs survival of fetal pig pancreas grafts in NOD mice. Transplantation Proceedings 24(5): 2289-2290

Nakane, A.; Okamoto, M.; Asano, M.; Kohanawa, M.; Minagawa, T. 1993: Anti-CD3 monoclonal antibody protects mice against a lethal bacterial infection through induction of endogenous cytokines. Journal of Interferon Research 13(Suppl 1): S97

Thierfelder, S.; Zengerle, U.; Hoffmann Fezer, G. 1994: Anti-CD3 monoclonal antibody suppresses normal and neoplastic human T- and B-cells in SCID mice. Experimental Hematology 22(8): 825

Hurwitz, H.I.; Weber, C.; Hauda, K.M.; Pardoll, D.M.; Levitsky, H.I.; Marshall, F.; Simons, J.W.; Nelson, W.G.; Carducci, M.; Jaffee, E.M. 1995: Anti-CD3 proliferative responses for evaluating general immune status of cancer patients pre/post tumor vaccination. Proceedings of the American Association for Cancer Research 36: 499

Radema, S.A.; Stronkhorst, A.; Van Deventer, S.J.H.; Tytgat, G.N.J. 1993: Anti-CD3 therapy abolishes HLA-DR expression on enterocytes. Gastroenterology 104(4 Suppl): A1059

Tran, G.; Carter, N.; Hodgkinson, S. 1998: Anti-CD3 therapy suppresses induction and reverses experimental allergic encephalomyelitis in Lewis rats. Journal of Neuroimmunology 90(1): 56

Weiner, G.J.; Hillstrom, J.R.; Belani, R. 1994: Anti-CD3-based bispecific antibody therapy induces rapid regression of established B-cell lymphoma. Clinical Research 42(3): 423A

Panoskaltsis Mortari, A.; Taylor, P.A.; Xu, J.; Vallera, D.A.; Blazar, B.R. 1995: Anti-CD3-epsilon monoclonal antibody prevents graft-vs-host disease mortality concomitant with decreased expression of costimulatory and adhesion molecules and inflammatory cytokines. FASEB Journal 9(3): A499

Merger, M.; Clark, D.A.; Steele Norwood, D.; Borojevic, R.; Riddell, R.H.; Croitoru, K. 1998: Anti-CD3-induced T cell enteropathy is not dependent on TNF-alpha mediated pathways. Gastroenterology 114(4 Part 2): A1038

Harris, W.G.; Gollapudi, S.; Gupta, S. 1993: Anti-CD3-mediated activation of PKC isoforms in human T cell subsets. Journal of Allergy and Clinical Immunology 91(1 Part 2): 214

Pescovitz, M.D.; Book, B.K. 1995: Anti-CD3-mediated enhancement of in vivo-generated allogeneic cytotoxicity. Surgical Forum 46: 411-413

Kinchington, D.; Ng, T.; Mathews, N.; Tisdale, M.; Devine, D.; Ayuko, W.O. 1997: Anti-CD3/2-chloro-5-nitrobenzoic acid costimulation differentially enhances T-cell growth without inducing HIV-1 replication. Antiviral Research 34(2): A59

Onlamoon, N.; Plagman, N.; Rogers, K.A.; Mayne, A.E.; Bostik, P.; Pattanapanyasat, K.; Ansari, A.A.; Villinger, F.ço. 2007: Anti-CD3/28 mediated expansion of macaque CD4+ T cells is polyclonal and provides extended survival after adoptive transfer. Journal of Medical Primatology 36(4-5): 206-218

Cafaro, A.; Pace, M.; Maggiorella, M.T.; Geraci, A.; Corrias, F.; Belli, R.; Carroll, R.G.; Levine, B.L.; St Louis, D.C.; June, C.H.; Titti, F.; Verani, P.; Ensoli, B. 1998: Anti-CD3/28-mediated expansion of T cells in the absence of SIV replication A novel animal model for immunotherapy. Journal of Medical Primatology 27(2-3): 172

Barth, S.; Engert, A.; Drillich, S.; Schoen, G.; Parsa Parsi, R.; Diehl, V.; Abken, H.; Hombach, A. 1998: Anti-CD30 interleukin-2 fusion protein for the treatment of Hodgkins lymphoma. Annals of Hematology 77(Suppl 2): S165

Hamann, P.R.; Hinman, L.M.; Hollander, I.J.; Hallett, W.A.; Holcomb, R.; Beyer, C.F.; Lindh, D. 1996: Anti-CD33 calicheamicin hybrid conjugates for the treatment of acute myelogenous leukemia. Proceedings of the American Association for Cancer Research 37: 471

Ellery, J.M.; Kempshall, S.J.; Emberson, L.M.; Nicholls, P.J. 1998: Anti-CD33 engineered lymphocytes for the treatment of myeloid leukaemia. Molecular Biology of the Cell 9(Suppl ): 478A

Shea, C.R.; Reed, J.A.; Prieto, V.G. 1993: Anti-CD34 immunostaining discriminates between scar and residual dermatofibrosarcoma protuberans. Journal of Investigative Dermatology 101(3): 404

Schultz, D.R.; Arnold, P.I.; Jy, W.; Valant, P.A.; Gruber, J.; Ahn, Y.S.; Wang, F.; Mao, W.W.; Horstman, L.L. 1998: Anti-CD36 autoantibodies in thrombocytopenic disorders Studies of a previously unrecognized 85 kD form of CD36. Blood 92(10 Suppl 1 Part 1-2): 175A

Itoh, T.; Taminato, T.; Kato, Y.; Natsume, H.; Suzuki, Y.; Sarwar, G.; Yoshimi, T.; Hazama, A.; Okada, Y. 1997: Anti-CD38 antibody modulates insulin secretion through some mechanism other than K-ATP channel. Diabetologia 40(Suppl 1): A109

Taussig, D.C.; Miraki-Moud, F.; Anjos-Afonso, F.; Pearce, D.J.; Allen, K.; Ridler, C.; Lillington, D.; Oakervee, H.; Cavenagh, J.; Agrawal, S.G.; Lister, T.Andrew.; Gribben, J.G.; Bonnet, D. 2008: Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112(3): 568-575

Taminato, T.; Itoh, T.; Natsume, H.; Katoh, H.; Yoshimi, T. 1997: Anti-CD38 autoantibody A new marker for potential IDDM A study with non-obese diabetic mouse. Diabetologia 40(Suppl 1): A94

Wong, J.T.; Maclean, J.A.; Colvin, R.B. 1994: Anti-CD3Anti-Il2 receptor bispecific monoclonal antibody Prevention of diabetes in nonobese diabetic mice. FASEB Journal 8(4-5): A967

Maclean, J.A.; Su, Z.; Colvin, R.B.; Wong, J.T. 1993: Anti-CD3anti-IL-2 receptor bispecific monoclonal antibody T cell immunomodulation with reduced activation and toxicity than anti-CD3 MAB in vivo. Journal of Immunology 150(8 Part 2): 189A

Wong, J.T.; Wecher, H.; Maclean, J.A.; Su, Z.; Colvin, R.B.; Auchincloss, H. 1993: Anti-CD3anti-IL2 receptor bispecific monoclonal antibody Prolongation of cardiac allograft survival with lower toxicity than anti-CD3 MAB. Journal of Immunology 150(8 Part 2): 249A

Blazar, B.R.; Jenkins, M.; Taylor, P.A.; White, J.; Panoskaltsis Mortari, A.; Korngold, R.; Vallera, D.A. 1997: Anti-CD3epsilonF 2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen. Blood 90(10 Suppl 1 Pt 1): 205A

Noort, W.A.; Benner, R.; Savelkoul, H.F. 1995: Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease. Transplantation Proceedings 27(1): 384-386

Devaux, C.; Benkirane, M. 1993: Anti-CD4 MAB-mediated suppression of HIV-1 genes transcription in T cells containing integrated provirus. Journal of Immunology 150(8 Part 2): 152A

Zagury, D. 1994: Anti-CD4 SLWDQ autoimmune reaction, a potential key initiator for AIDS pathogenesis. AIDS Research and Human Retroviruses 10(Suppl 1): S70

Keay, S.; Wecksler, W.; Wasserman, S.S.; (Usa), M.A.ds Cohort Study 1993: Anti-CD4 antibodies are associated with a specific decrease in CD4-positive lymphocytes in HIV-1 seroconverters. Abstracts of the General Meeting of the American Society for Microbiology 93: 435

Keiser, P.; Fernie, B.; Tacket, C.; Wecksler, W.; Keay, S. 1993: Anti-CD4 antibodies generated in response to HIV-1 rgp160 immunization of HIV-1-infected chimpanzees. Aids 7(1): 136-138

Shizuru, J.A.; Fathman, C.G. 1993: Anti-CD4 antibodies in diabetes. Immunology Series 59: 237-252

Hurez, V.; Kaveri, S.V.; Dietrich, G.; Klatzman, D.; Kazatchkine, M.D. 1994: Anti-CD4 antibodies in pooled normal immunoglobulins for therapeutic use. FASEB Journal 8(4-5): A484

Choi, S.H.; Splitter, G.A. 1993: Anti-CD4 antibody activates CD4-positive T lymphocytes to kill virally infected target cells in a non-MHC restricted fashion similar to that of NK cells. Journal of Immunology 150(8 Part 2): 114A

Ye, X.; Robinson, M.B.; Pabin, C.; Batshaw, M.L.; Wilson, J.M. 1997: Anti-CD4 antibody permits readministration of recombinant adenovirus to correct ornithine transcarbamylase deficiency in the sparse fur mice. Pediatric Research 41(4 Part 2): 109A

Attanasio, R.; Mcclure, H.M.; Scinicarriello, F. 1995: Anti-CD4 antibody responses elicited by DNA-based immunization. FASEB Journal 9(3): A515

Marchetti, P.; Scharp, D.W.; Finke, E.; Swanson, C.J.; Gerasimidi-Vazeou, A.; Olack, B.J.; Navalesi, R.; Lacy, P.E. 1994: Anti-CD4 antibody treatment in xenografts of differently immunomodulated porcine islets. Transplantation Proceedings 26(3): 1132

Martin, L.; Idziorek, T.; Lehen, A.; Gluckman, J.C.; Klatzmann, D. 1994: Anti-CD4 autoantibodies in HIV-infected individuals: detection by two immunoenzymatic techniques. Aids 8(3): 389-390

Sutor, G.C.; Schedel, I. 1996: Anti-CD4 idiotype vaccination in HIV diseases Results of a multicenter clinical phase-II-study. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Eleventh International Conference on AIDS, Vol Two One world: One hope : 23-24

Schedel, I.; Sutor, G.C.; Lang, S.; Jurkiewicz, E.; Hunsmann, G.; Hirn, M. 1995: Anti-CD4 idiotype vaccination in HIV-disease. Cancer Biotherapy 10(1): 78

Sutor, G.C.; Jurkiewicz, E.; Hunsmann, G.; Lundin, K.; Hirn, M.; Schedel, I. 1993: Anti-CD4 idiotype vaccination in early stage HIV-positive volunteers Results of a clinical Phase-IA Study. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 491

Broeker, B.M.; Chitaev, N.A.; Tsygankov, A.Y.; Guse, A.H.; Mueller Fleckenstein, I.; Fickenscher, H.; Fleckenstein, B.; Bolen, J.B.; Emmrich, F. 1992: Anti-CD4 inhibits human activated T cell clones immortalized by herpesvirus saimiri. Arthritis and Rheumatism 35(9 Suppl): S289

Wee, S.; Stroka, D.M.; D'Souza, G.; Fuller, T.C.; Fitzpatrick, D.M.; Cosimi, A.B. 1994: Anti-CD4 mAb therapy significantly delays the alloantibody response in a cynomolgus renal transplant model. Transplantation 58(2): 261-264

Choy, E.H.; Kingsley, G.H.; Panayi, G.S. 1998: Anti-CD4 monoclonal antibodies in rheumatoid arthritis. Springer Seminars in Immunopathology 20(1-2): 261-273

Shizuru, J.A.; Alters, S.E.; Fathman, C.G. 1992: Anti-CD4 monoclonal antibodies in therapy: creation of nonclassical tolerance in the adult. Immunological Reviews 129: 105-130

Takaishi, H.; Hibi, T.; Ezaki, T.; Yajima, T.; Inoue, N.; Ueno, Y.; Hosoda, Y.; Iwao, Y.; Toda, K.; Yamada, T.; Suzuki, T.; Watanabe, N.; Hamada, Y.; Watanabe, M.; Ishii, H. 1995: Anti-CD4 monoclonal antibody suppressed colonic inflammation in a novel rat colitis model induced by TNB immunization. Gastroenterology 108(4 Suppl): A925

Wood, K.; Bushell, A.; Dallman, M.; Darby, C.; Hamano, K.; Pearson, T.; Morris, P. 1993: Anti-CD4 monoclonal antibody therapy Induction of tolerance to alloantigens. European Surgical Research 25(6): 406-407

Adams, D.H.; Sayegh, M.H.; Hancock, W.W.; Wyner, L.R.; Karnovsky, M.J. 1993: Anti-CD4 monoclonal antibody therapy alters cytokine expression and limits intimal hyperplasia following arterial balloon injury. Surgical Forum 44: 347-349

Reinke, P.; Kern, F.; Fietze, E.; Doecke, W.D.; Ewert, R.; Emmrich, F.; Volk, H.D. 1994: Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients. Nephrology Dialysis Transplantation 9(7): 1043